1
|
Qin H, Dewan P, Santema BT, Ter Maaten JM, Swedberg K, McMurray JJV, Voors AA. Achieved dose and treatment discontinuation of candesartan in men and women with chronic heart failure: data from CHARM. ESC Heart Fail 2024. [PMID: 38581132 DOI: 10.1002/ehf2.14715] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/05/2023] [Revised: 01/11/2024] [Accepted: 01/18/2024] [Indexed: 04/08/2024] Open
Abstract
AIMS Angiotensin receptor blockers have been shown to reduce heart failure hospitalization and cardiovascular mortality in men and women with heart failure with reduced ejection fraction (HFrEF). It is unknown whether there are differences between men and women in achieved dose and treatment discontinuation due to adverse events of candesartan. METHODS AND RESULTS We conducted a post hoc analysis of the Candesartan in Heart failure: Assessment of Reduction in Mortality and morbidity (CHARM) programme. A total of 3172 men and 1106 women with HFrEF [left ventricular ejection fraction (LVEF) ≤ 40%] in New York Heart Association class II-IV were randomized to candesartan or placebo. Every 2 weeks, patients were up-titrated from 4 or 8, to16, to 32 mg once daily, unless a higher dose was contraindicated or not tolerated. Women were older (66 vs. 64 years), had a higher LVEF (29.9% vs. 28.6%), and had more hypertension (54% vs. 47%) than men. The mean achieved dose of candesartan was 21.5 ± 12.6 mg in men and 20.7 ± 12.9 mg in women (P = 0.19). In both the candesartan and placebo groups, cardiovascular death and heart failure hospitalizations were higher in men and women who achieved lower dose levels. Event rates for achieved dose levels of 0, 4 or 8, 16, and 32 mg candesartan were 20.8, 17.2, 14.0, and 10.1 per 100 person-years in men, respectively, and 23.6, 13.7, 14.0, and 9.1 per 100 person-years in women, respectively. In each of the achieved dose levels, there was no sex difference in the proportion of patients with an event, neither in the candesartan group nor in the placebo group (P-value for all > 0.05). There was no significant interaction between sex and treatment-related discontinuation for hypotension (P = 0.520), an increase in creatinine (P = 0.102), and hyperkalaemia (P = 0.905). CONCLUSIONS In a randomized clinical trial in patients with HFrEF, men and women achieved similar doses of candesartan. Primary event rates and treatment-related discontinuation due to adverse events were also similar between men and women.
Collapse
Affiliation(s)
- Hailun Qin
- Department of Cardiology, University Medical Center Groningen, University of Groningen, Hanzeplein 1, 9713 GZ, Groningen, The Netherlands
| | - Pooja Dewan
- British Heart Foundation Cardiovascular Research Centre, University of Glasgow, Glasgow, UK
| | - Bernadet T Santema
- Department of Cardiology, University Medical Center Groningen, University of Groningen, Hanzeplein 1, 9713 GZ, Groningen, The Netherlands
| | - Jozine M Ter Maaten
- Department of Cardiology, University Medical Center Groningen, University of Groningen, Hanzeplein 1, 9713 GZ, Groningen, The Netherlands
| | - Karl Swedberg
- Department of Molecular and Clinical Medicine, University of Gothenburg, Gothenburg, Sweden
| | - John J V McMurray
- British Heart Foundation Cardiovascular Research Centre, University of Glasgow, Glasgow, UK
| | - Adriaan A Voors
- Department of Cardiology, University Medical Center Groningen, University of Groningen, Hanzeplein 1, 9713 GZ, Groningen, The Netherlands
| |
Collapse
|
2
|
Chyou JY, Qin H, Butler J, Voors AA, Lam CSP. Sex-related similarities and differences in responses to heart failure therapies. Nat Rev Cardiol 2024:10.1038/s41569-024-00996-1. [PMID: 38459252 DOI: 10.1038/s41569-024-00996-1] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Accepted: 02/01/2024] [Indexed: 03/10/2024]
Abstract
Although sex-related differences in the epidemiology, risk factors, clinical characteristics and outcomes of heart failure are well known, investigations in the past decade have shed light on an often overlooked aspect of heart failure: the influence of sex on treatment response. Sex-related differences in anatomy, physiology, pharmacokinetics, pharmacodynamics and psychosocial factors might influence the response to pharmacological agents, device therapy and cardiac rehabilitation in patients with heart failure. In this Review, we discuss the similarities between men and women in their response to heart failure therapies, as well as the sex-related differences in treatment benefits, dose-response relationships, and tolerability and safety of guideline-directed medical therapy, device therapy and cardiac rehabilitation. We provide insights into the unique challenges faced by men and women with heart failure, highlight potential avenues for tailored therapeutic approaches and call for sex-specific evaluation of treatment efficacy and safety in future research.
Collapse
Affiliation(s)
- Janice Y Chyou
- Cardiovascular Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA
| | - Hailun Qin
- Department of Cardiology, University of Groningen, University Medical Centre Groningen, Groningen, Netherlands
| | - Javed Butler
- Department of Medicine, University of Mississippi School of Medicine, Jackson, MS, USA
- Baylor Scott and White Research Institute, Dallas, TX, USA
| | - Adriaan A Voors
- Department of Cardiology, University of Groningen, University Medical Centre Groningen, Groningen, Netherlands
| | - Carolyn S P Lam
- National Heart Centre Singapore and Duke-NUS Medical School, Singapore, Singapore.
| |
Collapse
|
3
|
Huang YT, Chen YQ, Qin H, Wen H, Liu WL, Liu YH, Liang R, Jin YL. [Calculus around tracheotomy tube in a child: a case report]. Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi 2024; 59:171-173. [PMID: 38369797 DOI: 10.3760/cma.j.cn115330-20231031-00179] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 02/20/2024]
Affiliation(s)
- Y T Huang
- Department of Otolaryngology Head and Neck Surgery, Guangzhou Medical University Women and Children's Medical Center, Guangdong Provincial Clinical Research Center for Child Health, Guangzhou 510623, China
| | - Y Q Chen
- Department of Otolaryngology Head and Neck Surgery, Guangzhou Medical University Women and Children's Medical Center, Guangdong Provincial Clinical Research Center for Child Health, Guangzhou 510623, China
| | - H Qin
- Department of Otolaryngology Head and Neck Surgery, Guangzhou Medical University Women and Children's Medical Center, Guangdong Provincial Clinical Research Center for Child Health, Guangzhou 510623, China
| | - H Wen
- Department of Otolaryngology Head and Neck Surgery, Guangzhou Medical University Women and Children's Medica Center Liuzhou Hospital, Liuzhou 545000, China
| | - W L Liu
- Department of Otolaryngology Head and Neck Surgery, Guangzhou Medical University Women and Children's Medical Center, Guangdong Provincial Clinical Research Center for Child Health, Guangzhou 510623, China
| | - Y H Liu
- Department of Otolaryngology Head and Neck Surgery, Guangzhou Medical University Women and Children's Medical Center, Guangdong Provincial Clinical Research Center for Child Health, Guangzhou 510623, China
| | - R Liang
- Department of Anesthesiology, Guangzhou Medical University Women and Children's Medical Center, Guangzhou 510623, China
| | - Y L Jin
- Department of Anesthesiology, Guangzhou Medical University Women and Children's Medical Center, Guangzhou 510623, China
| |
Collapse
|
4
|
Lyu TY, Li M, He JA, Sun QF, Wang L, Qin H, Yu HP. [Analysis of the experience and procedural complications of trans-radial access versus trans-femoral access for hepatic arterial perfusion chemotherapy in patients with advanced hepatic malignancies:a retrospective study]. Zhonghua Nei Ke Za Zhi 2024; 63:183-191. [PMID: 38326045 DOI: 10.3760/cma.j.cn112138-20230827-00087] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Grants] [Subscribe] [Scholar Register] [Indexed: 02/09/2024]
Abstract
Objective: To analyze the differences between trans-radial access (TRA) and trans-femoral access (TFA) in hepatic arterial perfusion chemotherapy (HAIC) in terms of patient experience, postoperative complications, and patient preferences; explore whether TRA in HAIC is associated with better patient experience and compliance; and determine whether it is safer than TFA. Methods: The study was a retrospective cohort study of patients with advanced hepatocellular carcinoma and liver metastases from colorectal cancer treated with HAIC. We enrolled a total of 91 patients with advanced liver malignancies treated with HAIC from November 2022 to May 2023 in the Department of Interventional Therapy and Hepatobiliary Medicine at Tianjin Medical University Cancer Hospital. The patients were divided into three groups: group TRA (n=20, receiving TRA HAIC only), group TFA (n=33, receiving TFA HAIC only), and crossover group [n=19, receiving TFA HAIC (Cross-TFA group) first, followed by TRA HAIC (Cross-TRA group)]. Meanwhile, to facilitate the expression of partial results, all patients receiving TRA HAIC were defined as the TRA-HAIC group (n=39, TRA+Cross-TRA group), and all patients receiving TFA HAIC were defined as the TFA-HAIC group (n=52, TFA+Cross-TFA group). The primary research index was the Quality of Life (QOL) visualization scale score. The secondary research index included approach-related and catheter-related adverse events, duration of surgery, and mean length of patient stay. We used various statistical methods such as Mann-Whitney U test, t-test, Chi-square test, Fisher's exact test, univariate logistic regression analysis, and multi-factor analysis. Results: TRA patients had significantly lower QOL scores than TFA patients (all P<0.001). The QOL scores of the Cross-TRA group were significantly lower than those of the Cross-TFA group (pain at the puncture site Z=-3.24, P=0.001, others P<0.001). The QOL scores of the Cross-TRA group were compared with those of the TRA group, which showed that the scores of the Cross-TRA group in overall discomfort (Z=-3.07,P=0.002), postoperative toilet difficulty (Z=-2.12, P=0.034), and walking difficulty (Z=-2.58, P=0.010) were significantly lower than those of the TRA group. Satisfaction scores were significantly higher in the Cross-TRA group than in the Cross-TFA group (Z=-3.78, P<0.001), and patients were more likely to receive TRA HAIC as the next procedure (χ2=30.42, P<0.001). In terms of mean length of stay, patients receiving TRA HAIC had a significantly lower mean length of stay than those receiving TFA HAIC (50.1±3.2 h vs. 58.4±6.4 h, t=7.98, P<0.001). The incidence of radial artery occlusion (RAO) as an approach-related adverse event was 15.4% (6/39) in the TRA-HAIC group, which was significantly higher than that in the TFA-HAIC group (15.4% vs. 0, χ2=8.56, P=0.005). Notably, multifactorial analysis of RAO-related factors showed that intraoperative enoxaparin use and patency of radial artery flow during pressure were significantly associated with a reduced risk of postoperative RAO (P=0.037 for enoxaparin use and P=0.049 for pressure). Conclusions: With respect to procedure approach, TRA was significantly better than TFA in terms of patient satisfaction and mean length of stay. Through further process optimization and prevention of adverse reactions, the incidence of adverse reactions can be maintained at a relatively low level, so that patients can benefit from TRA in future operations in terms of cost-effectiveness and medical efficiency.
Collapse
Affiliation(s)
- T Y Lyu
- Department of Interventional Therapy, Tianjin Medical University Cancer Institute & Hospital, National Clinical Research Center for Cancer, Tianjin's Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin 300060, China Department Of Oncology of the 983rd Hospital of the Chinese People's Liberation Army Joint Logistic Support Force, Tianjin 300142, China
| | - M Li
- Department of Interventional Therapy, Tianjin Medical University Cancer Institute & Hospital, National Clinical Research Center for Cancer, Tianjin's Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin 300060, China
| | - J A He
- Department of Interventional Therapy, Tianjin Medical University Cancer Institute & Hospital, National Clinical Research Center for Cancer, Tianjin's Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin 300060, China
| | - Q F Sun
- Department of Interventional Therapy, Tianjin Medical University Cancer Institute & Hospital, National Clinical Research Center for Cancer, Tianjin's Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin 300060, China
| | - L Wang
- Department of Interventional Therapy, Tianjin Medical University Cancer Institute & Hospital, National Clinical Research Center for Cancer, Tianjin's Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin 300060, China
| | - H Qin
- Department of Interventional Therapy, Tianjin Medical University Cancer Institute & Hospital, National Clinical Research Center for Cancer, Tianjin's Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin 300060, China
| | - H P Yu
- Department of Interventional Therapy, Tianjin Medical University Cancer Institute & Hospital, National Clinical Research Center for Cancer, Tianjin's Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin 300060, China
| |
Collapse
|
5
|
He Y, Qin H, Song JL. [Orthodontic treatment before restoration of dentition defects]. Zhonghua Kou Qiang Yi Xue Za Zhi 2023; 58:899-905. [PMID: 37659847 DOI: 10.3760/cma.j.cn112144-20230626-00251] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Grants] [Subscribe] [Scholar Register] [Indexed: 09/04/2023]
Abstract
Dentition defects damage the integrity of the dental arch, affecting smile esthetics and oral function. Compared to restorative treatment, pre-restoration orthodontic treatment overcomes the limitations of a single method, effectively avoiding excessive wear of natural teeth, reducing the number of units for restorative production to a certain extent, and potentially improving facial shape and occlusal relationship, which maximizes the therapeutic effect. This article explores the key points of pre-restoration orthodontic treatment for different types of dentition defects in terms of malocclusion manifestations, treatment objectives, treatment methods, and maintenance recommendations from the perspective of combined orthodontic restoration treatment.
Collapse
Affiliation(s)
- Y He
- Department of Orthodontics, Stomatological Hospital of Chongqing Medical University & Chongqing Key Laboratory of Oral Diseases and Biomedical Sciences & Chongqing Municipal Key Laboratory of Oral Biomedical Engineering of Higher Education, Chongqing 401147, China
| | - H Qin
- Department of Prosthodontics, Stomatological Hospital of Chongqing Medical University & Chongqing Key Laboratory of Oral Diseases and Biomedical Sciences & Chongqing Municipal Key Laboratory of Oral Biomedical Engineering of Higher Education, Chongqing 401147, China
| | - J L Song
- Department of Orthodontics, Stomatological Hospital of Chongqing Medical University & Chongqing Key Laboratory of Oral Diseases and Biomedical Sciences & Chongqing Municipal Key Laboratory of Oral Biomedical Engineering of Higher Education, Chongqing 401147, China
| |
Collapse
|
6
|
Gao F, Hu Y, Li X, Li H, Wang S, Zeng Z, Qin H. 412P Substance-P in the blood is related with the efficacy of aprepitant for targeted drug-induced refractory pruritus in Chinese malignancy population. Ann Oncol 2022. [DOI: 10.1016/j.annonc.2022.10.443] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/07/2022] Open
|
7
|
Wang S, Gao F, Zeng Z, Qin H. 250P An analysis of nutritional and psychological status of patients with advanced cancer. Ann Oncol 2022. [DOI: 10.1016/j.annonc.2022.10.063] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/05/2022] Open
|
8
|
Qin H, Zeng Z, Wang S, Gao F, Liu X. 351P Real-world study of herombopag in primary prevention and treatment of chemotherapy-induced thrombocytopenia (CIT) in advanced lung cancer. Ann Oncol 2022. [DOI: 10.1016/j.annonc.2022.10.389] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/05/2022] Open
|
9
|
Zeng Z, Wang S, Gao F, Qin H. 350P Primary prevention of chemotherapy-induced neutropenia in patients with advanced lung cancer in real-world research. Ann Oncol 2022. [DOI: 10.1016/j.annonc.2022.10.388] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/05/2022] Open
|
10
|
Qin H, Santema BT, Emmens JE, Van Essen BJ, Gansevoort RT, Bakker SJL, De Boer RA, Voors AA. Sex versus gender-related differences in new-onset heart failure with preserved and reduced left ventricular ejection fraction. Eur Heart J 2022. [DOI: 10.1093/eurheartj/ehac544.882] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
Abstract
Abstract
Aims
Sex refers to genetic and biological characteristics, whereas gender reflects psychosocial norms, roles and behaviors. Sex differences in new-onset heart failure are well described, but gender differences in new-onset heart failure with preserved (HFpEF) and reduced left ventricular ejection fraction (HFrEF) are unknown.
Methods
A total of 6830 participants (50.3% women, mean age of 54 years) from the Prevention of Renal and Vascular End-Stage Disease (PREVEND) observational Dutch cohort were enrolled in the study. Gender-related characteristics were assessed using self-administered questionnaires. LASSO regression analysis selected the psychosocial variables related to sex, whose coefficient estimates were used to calculate the gender-related scores for each subject [1–2]. The participants were grouped by sex and further analyzed according to tertiles of the gender-related score. Competing-risk regression analysis was used to assess whether sex and gender were associated with new-onset HFrEF (LVEF ≤40%) and HFpEF (LVEF ≥50%).
Results
Women with predominantly masculine gender had lower BMI, were more often Caucasian and had higher total cholesterol and high-density lipoprotein (HDL) levels than women with a predominantly feminine gender. Men with predominantly feminine gender were less often Caucasian with lower total cholesterol and HDL cholesterol levels than men with a predominantly masculine gender. During a median follow-up of 8.3 years, 227 (3.3%) subjects were diagnosed with heart failure (57.3% HFrEF and 43.7% HFpEF). In the total population including both men and women, feminine gender was significantly and independently associated with a higher risk of new-onset HFpEF compared with masculine gender (HR per 10 point: 1.17, 95% CI: 1.06–1.30; p=0.003). However, sex was not associated with new-onset HFpEF (HR: 1.09, 95% CI: 0.73–1.62; p=0.670). Separately in men, feminine gender was associated with a higher risk of new-onset HFpEF (HR: 1.37, 95% CI: 1.06–1.78; p=0.017), but not in women (HR: 1.13, 95% CI: 0.90–1.41; p=0.310).
Conclusions
Gender and sex are different constructs and feminine gender was associated with an increased risk of new-onset HFpEF, whereas sex was not associated with new-onset HFpEF.
Funding Acknowledgement
Type of funding sources: Foundation. Main funding source(s): Dutch Kidney Foundation
Collapse
Affiliation(s)
- H Qin
- University Medical Center Groningen, Cardiology , Groningen , The Netherlands
| | - B T Santema
- University Medical Center Groningen, Cardiology , Groningen , The Netherlands
| | - J E Emmens
- University Medical Center Groningen, Cardiology , Groningen , The Netherlands
| | - B J Van Essen
- University Medical Center Groningen, Cardiology , Groningen , The Netherlands
| | - R T Gansevoort
- University Medical Center Groningen, Nephrology , Groningen , The Netherlands
| | - S J L Bakker
- University Medical Center Groningen, Nephrology , Groningen , The Netherlands
| | - R A De Boer
- University Medical Center Groningen, Cardiology , Groningen , The Netherlands
| | - A A Voors
- University Medical Center Groningen, Cardiology , Groningen , The Netherlands
| |
Collapse
|
11
|
Yang Y, Dong C, Sun C, Wang K, Zhang W, Zheng WP, Zhang FB, Qin H, Han C, Wang Z, Xu M, Gao W. [The effect of steatotic donor livers on the prognosis of donors and recipients after pediatric living donor liver transplantation]. Zhonghua Wai Ke Za Zhi 2022; 60:922-929. [PMID: 36207981 DOI: 10.3760/cma.j.cn112139-20220412-00159] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 06/16/2023]
Abstract
Objectives: To evaluate the effects of steatotic donor livers on the safety of donors and the prognosis of donors and recipients in pediatric living donor liver transplantation. Methods: A total of 814 pediatric living donor liver transplantations were performed between January 2013 and December 2020 at Department of Pediatric Organ Transplantation,Tianjin First Central Hospital.The clinical data were collected and a retrospective study was conducted.The recipients and the donors were divided into non-steatotic donor liver group(n=733) and steatotic donor liver group(n=81) according to whether the donor graft had steatosis. The recipients and the donors in the steatotic donor liver group were further divided into mild and moderate steatosis groups based on the degree of liver steatosis.Among the donors of non-steatosis donor group,there were 307 males and 426 females,with a median age of 30 years(range:18 to 57 years);the recipients included 351 males and 382 females,with a median age of 7 months(range:4 month to 14 years).Among the donors of steatosis donor group,there were 41 males and 40 females,with a median age of 31 years(range:22 to 51 years);the recipients included 34 males and 47 females,with a median age of 8 months(range:5 months to 11 years).The donors and the recipients were followed up regularly by means of outpatient reexamination and questionnaire survey after operation.Statistical analysis of data between groups was performed using t-test,Wilcoxon rank-sum test,repeated measures ANOVA,χ2 test,or Fisher's exact test,respectively.The survival curves of recipients and grafts in different groups were created by Kaplan-Meier method,and the survival rates of the steatotic donor liver group and the non-steatotic donor liver group were compared by Log-rank method. Results: There was no significant difference in the gender of donors in both groups (P=0.132).There were significant differences in the age and blood type distribution as well as body weight and body mass index(all P<0.05) between the two groups.No significant difference was seen in the recovery of liver function markers ALT and AST at 1,2,5 days and 1 month after operation (all P>0.05) between the two groups.The steatotic donor liver group showed longer operation time ((294±75) minutes vs. (264±81) minutes; t=3.149,P=0.002),increased incidence of postoperative biliary leakage (3.7%(3/81) vs. 0.5% (4/733); P=0.025) and delayed incision healing (7.4%(6/81) vs. 2.0%(15/733); P=0.013).There were no significant differences in gender,age,blood type distribution,height,weight and pediatric end-stage liver disease score of recipients between the two groups (all P>0.05).As compared to the non-steatotic donor liver group,the steatotic donor liver group showed similar levels of ALT, AST and total bilirubin within 2 weeks after operation(all P>0.05). The cumulative recipient survival rates in both groups were both 96.3%,the cumulative graft survival rates were 96.3% and 95.5%,respectively,without significant difference(both P>0.05). No statistical difference was observed in the incidence of major complications between the two groups (all P>0.05). There was no significant difference in the recovery of liver function markers of donors and recipients between mild and moderate steatosis groups(all P>0.05).The cumulative recipient survival rates were both 95.9% and the cumulative graft survival rates were both 100% in mild and moderate steatosis groups,without significant difference(P=0.592). Conclusions: The application of mild to moderate steatotic donor livers in pediatric living donor liver transplantation may prolong the operation time of donors,increase the incidence of complications such as biliary leakage and delayed incision healing. But there is no significant impact of mild to moderate steatotic donor livers on the overall postoperative recovery of donors and recipients,and the prognosis is ideal.
Collapse
Affiliation(s)
- Y Yang
- Department of Pediatric Organ Transplantation,Organ Transplantation Center,Tianjin First Central Hospital,Key Laboratory of Transplantation,Chinese Academy of Medical Sciences,Tianjin 300192,China
| | - C Dong
- Department of Pediatric Organ Transplantation,Organ Transplantation Center,Tianjin First Central Hospital,Key Laboratory of Transplantation,Chinese Academy of Medical Sciences,Tianjin 300192,China
| | - C Sun
- Department of Pediatric Organ Transplantation,Organ Transplantation Center,Tianjin First Central Hospital,Key Laboratory of Transplantation,Chinese Academy of Medical Sciences,Tianjin 300192,China
| | - K Wang
- Department of Pediatric Organ Transplantation,Organ Transplantation Center,Tianjin First Central Hospital,Key Laboratory of Transplantation,Chinese Academy of Medical Sciences,Tianjin 300192,China
| | - W Zhang
- Department of Pediatric Organ Transplantation,Organ Transplantation Center,Tianjin First Central Hospital,Key Laboratory of Transplantation,Chinese Academy of Medical Sciences,Tianjin 300192,China
| | - W P Zheng
- Department of Pediatric Organ Transplantation,Organ Transplantation Center,Tianjin First Central Hospital,Key Laboratory of Transplantation,Chinese Academy of Medical Sciences,Tianjin 300192,China
| | - F B Zhang
- Department of Pediatric Organ Transplantation,Organ Transplantation Center,Tianjin First Central Hospital,Key Laboratory of Transplantation,Chinese Academy of Medical Sciences,Tianjin 300192,China
| | - H Qin
- Department of Pediatric Organ Transplantation,Organ Transplantation Center,Tianjin First Central Hospital,Key Laboratory of Transplantation,Chinese Academy of Medical Sciences,Tianjin 300192,China
| | - C Han
- Department of Pediatric Organ Transplantation,Organ Transplantation Center,Tianjin First Central Hospital,Key Laboratory of Transplantation,Chinese Academy of Medical Sciences,Tianjin 300192,China
| | - Z Wang
- Department of Pediatric Organ Transplantation,Organ Transplantation Center,Tianjin First Central Hospital,Key Laboratory of Transplantation,Chinese Academy of Medical Sciences,Tianjin 300192,China
| | - M Xu
- Department of Pediatric Organ Transplantation,Organ Transplantation Center,Tianjin First Central Hospital,Key Laboratory of Transplantation,Chinese Academy of Medical Sciences,Tianjin 300192,China
| | - W Gao
- Department of Pediatric Organ Transplantation,Organ Transplantation Center,Tianjin First Central Hospital,Key Laboratory of Transplantation,Chinese Academy of Medical Sciences,Tianjin 300192,China
| |
Collapse
|
12
|
Han Z, Feng M, Wu X, Su C, Yuan YC, Qin H, Zain J, Akilov O, Rosen ST, Querfeld C. Dual blocking of CD47 and PD-L1 increases innate and adaptive immune responses in CTCL. Eur J Cancer 2022. [DOI: 10.1016/s0959-8049(22)00552-4] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/03/2022]
|
13
|
Klein M, Watson D, Castro M, Kapoor S, Nair P, Rajagopalan S, Macpherson M, Christie J, Alam A, Qin H, Glaser M, Lala D, Prasad S, G P, Ullal Y, Sahu D, Kulkarni S, Narvekar Y, Ghosh A, Choudhury S, Birajdar S, Roy K, Singh D, Kumar C, Joseph V, Mundkur N, Patel S, Ganti A. EP16.03-024 Cellworks Singula™ Therapy Response Index (TRI) Identifies Superior OS Outcomes for NSCLC Patients: myCare-203A. J Thorac Oncol 2022. [DOI: 10.1016/j.jtho.2022.07.1085] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/17/2022]
|
14
|
Wang Z, Zhao Z, Xia Y, Cai Z, Wang C, Shen Y, Liu R, Qin H, Jia J, Yuan G. Potential biomarkers in the fibrosis progression of nonalcoholic steatohepatitis (NASH). J Endocrinol Invest 2022; 45:1379-1392. [PMID: 35226336 DOI: 10.1007/s40618-022-01773-y] [Citation(s) in RCA: 6] [Impact Index Per Article: 3.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 12/14/2021] [Accepted: 02/17/2022] [Indexed: 12/13/2022]
Abstract
PURPOSE Fibrosis is the only histological feature reflecting the severity and prognosis of nonalcoholic steatohepatitis (NASH). We aim to explore novel genes associated with fibrosis progression in NASH. METHODS Two human RNA-seq datasets were downloaded from the public database. Weighted gene co-expression network analysis (WGCNA) was used to identify their co-expressed modules and further bioinformatics analysis was performed to identify hub genes within the modules. Finally, based on two single-cell RNA-seq datasets from mice and one microarray dataset from human, we further observed the expression of hub genes in different cell clusters and liver tissues. RESULTS 7 hub genes (SPP1, PROM1, SOX9, EPCAM, THY1, CD34 and MCAM) associated with fibrosis progression were identified. Single-cell RNA-seq analysis revealed that those hub genes were expressed by different cell clusters such as cholangiocytes, natural killer (NK) cells, and hepatic stellate cells (HSCs). We also found that SPP1 and CD34 serve as markers of different HSCs clusters, which are associated with inflammatory response and fibrogenesis, respectively. Further study suggested that SPP1, SOX9, MCAM and THY1 might be related to NASH-associated hepatocellular carcinoma (HCC). Receiver operating characteristic (ROC) analysis showed that the high expression of these genes could well predict the occurrence of HCC. At the same time, there were significant differences in metabolism-related pathway changes between different HCC subtypes, and SOX9 may be involved in these changes. CONCLUSIONS The present study identified novel genes associated with NASH fibrosis and explored their effects on fibrosis from a single-cell perspective that might provide new ideas for the early diagnosis, monitoring, evaluation, and prediction of fibrosis progression in NASH.
Collapse
Affiliation(s)
- Z Wang
- Department of Endocrinology, Affiliated Hospital of Jiangsu University, Zhenjiang, 212001, Jiangsu, China
| | - Z Zhao
- Department of Endocrinology, Affiliated Hospital of Jiangsu University, Zhenjiang, 212001, Jiangsu, China
| | - Y Xia
- Department of Endocrinology, Affiliated Hospital of Jiangsu University, Zhenjiang, 212001, Jiangsu, China
| | - Z Cai
- Department of Endocrinology, Affiliated Hospital of Jiangsu University, Zhenjiang, 212001, Jiangsu, China
| | - C Wang
- Department of Endocrinology, Affiliated Hospital of Jiangsu University, Zhenjiang, 212001, Jiangsu, China
| | - Y Shen
- Department of Endocrinology, Affiliated Hospital of Jiangsu University, Zhenjiang, 212001, Jiangsu, China
| | - R Liu
- Department of Endocrinology, Affiliated Hospital of Jiangsu University, Zhenjiang, 212001, Jiangsu, China
| | - H Qin
- Department of Endocrinology, Affiliated Hospital of Jiangsu University, Zhenjiang, 212001, Jiangsu, China
| | - J Jia
- Department of Endocrinology, Affiliated Hospital of Jiangsu University, Zhenjiang, 212001, Jiangsu, China.
| | - G Yuan
- Department of Endocrinology, Affiliated Hospital of Jiangsu University, Zhenjiang, 212001, Jiangsu, China.
| |
Collapse
|
15
|
Meng X, Duan X, Zhang L, Zhang D, Yang P, Qin H, Zhang Y, Xiao S, Duan L, Zhou R. Long-Chain Alkane Dehydrogenation over Hierarchically Porous Ti-Doped Pt–Sn–K/TiO2–Al2O3 Catalysts. Kinet Catal 2022. [DOI: 10.1134/s0023158422020070] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 11/23/2022]
|
16
|
Dobranowski P, Qin H, Walker K, Butcher J, Gowing A, Singleton R, Mayne J, Mack DR, Figeys D, Stintzi A. A234 IN VITRO GUT MICROBIOME AND METABOLITE RESPONSES TO RESISTANT STARCH ARE INDIVIDUALIZED. J Can Assoc Gastroenterol 2022. [PMCID: PMC8859390 DOI: 10.1093/jcag/gwab049.233] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Download PDF] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/28/2022] Open
Abstract
Background Gut microbes degrade and ferment resistant starch (RS) into metabolites that help maintain gut homeostasis. Clinical trials have evaluated RS for various health conditions, but individuals respond to RS with profound variability. The reason for this variability is unclear. Aims Using in vitro culturing methods and multi-omic analyses, we hypothesize that individuals will elicit variable responses to RS with respect to overall fermentation, bacterial composition, short chain acid production, and metabolite flux. Methods As part of an ongoing clinical trial, we have selected 4 pediatric patients with inflammatory bowel disease to better understand microbiome-RS interactions. We cultured stools anaerobically using a high-throughput platform (“RapidAIM”) with 9 different pre-digested RS. After 18-hour incubations, media supernatants were used to measure pH and perform targeted and semi-targeted metabolomic analyses with a panel of 116 compounds. Bacterial pellets were isolated for 16S rRNA gene sequencing analyses to evaluate changes in microbiome compositions. Data were analyzed with generalized linear mixed models, principal component analysis (PCA), random forest (RF) classification with feature selection, and network construction with graphical lasso. Results Changes in several microbiome parameters were different across individuals, including the magnitude of pH changes, metabolite signatures, and relative abundances of important bacterial taxa. Bacterial species known to degrade RS were more abundant in individuals showing stronger RS fermentation. Inter-individual discrimination was accomplished with PCA and RF, from which we could identify metabolite signatures. The robustness of microbiome networks corresponded to RS fermentation and butyrate production. Conclusions We report a novel perspective on how individuals respond to RS’ differently. Butyrate remains an important hub of the microbiome architecture with respect to RS fermentation. Future work will interrogate the roles of individualized metabolomic responses on host physiology. In vivo responses to RS are being evaluated in an ongoing clinical trial. Funding Agencies CCC, CIHRGenome Ontario, Genome Canada
Collapse
Affiliation(s)
- P Dobranowski
- Biochemistry, Microbiology and Immunology, University of Ottawa Faculty of Medicine, Surrey, BC, Canada
| | - H Qin
- Biochemistry, Microbiology and Immunology, University of Ottawa Faculty of Medicine, Surrey, BC, Canada
| | - K Walker
- Biochemistry, Microbiology and Immunology, University of Ottawa Faculty of Medicine, Surrey, BC, Canada
| | - J Butcher
- Biochemistry, Microbiology and Immunology, University of Ottawa Faculty of Medicine, Surrey, BC, Canada
| | - A Gowing
- Children’s Hospital of Eastern Ontario, Ottawa, ON, Canada
| | - R Singleton
- Children’s Hospital of Eastern Ontario, Ottawa, ON, Canada
| | - J Mayne
- Biochemistry, Microbiology and Immunology, University of Ottawa Faculty of Medicine, Surrey, BC, Canada
| | - D R Mack
- Children’s Hospital of Eastern Ontario, Ottawa, ON, Canada
| | - D Figeys
- Biochemistry, Microbiology and Immunology, University of Ottawa Faculty of Medicine, Surrey, BC, Canada
| | - A Stintzi
- Biochemistry, Microbiology and Immunology, University of Ottawa Faculty of Medicine, Surrey, BC, Canada
| |
Collapse
|
17
|
Zhang Y, Zeng L, Li Y, Song L, Qin H, Yan H, Huang Z, Mi J, Yang N. 152P Immunotherapy-based strategies displayed a promising efficacy in non-small cell lung cancer (NSCLC) patients with non-EGFR oncogenic genetic alterations. Ann Oncol 2021. [DOI: 10.1016/j.annonc.2021.10.171] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/25/2022] Open
|
18
|
Peng JB, Peng YT, Lin P, Wan D, Qin H, Li X, Wang XR, He Y, Yang H. Differentiating infected focal liver lesions from malignant mimickers: value of ultrasound-based radiomics. Clin Radiol 2021; 77:104-113. [PMID: 34753587 DOI: 10.1016/j.crad.2021.10.009] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/29/2020] [Accepted: 10/11/2021] [Indexed: 12/12/2022]
Abstract
AIM To establish an ultrasound-based radiomics model through machine learning methods and then to assess the ability of the model to differentiate infected focal liver lesions from malignant mimickers. MATERIALS AND METHODS A total of 104 patients with infected focal liver lesions and 485 patients with malignant hepatic tumours were included, consisting of hepatocellular carcinoma (HCC), cholangiocarcinoma (CC), combined hepatocellular-cholangiocarcinoma (cHCC-CC), and liver metastasis. Radiomics features were extracted from grey-scale ultrasound images. Feature selection and predictive modelling were carried out by dimensionality reduction methods and classifiers. The diagnostic effect of the prediction mode was assessed by receiver operating characteristic (ROC) curve analysis. RESULTS In total, 5,234 radiomics features were extracted from grey-scale ultrasound image of every focal liver lesion. The ultrasound-based radiomics model had a favourable predictive value for differentiating infected focal liver lesions from malignant hepatic tumours, with an area under the curve (AUC) of 0.887 and 0.836 (HCC group), 0.896 and 0.766 (CC group), 0.944 and 0.754 (cHCC-CC group), 0.918 and 0.808 (liver metastasis group), and 0.949 and 0.745 (malignant hepatic tumour group) for the training set and validation set, respectively. CONCLUSIONS Ultrasound-based radiomics is helpful in differentiating infected focal liver lesions from malignant mimickers and has the potential for use as a supplement to conventional grey-scale ultrasound and contrast-enhanced ultrasound (CEUS).
Collapse
Affiliation(s)
- J B Peng
- Department of Medical Ultrasonics, First Affiliated Hospital of Guangxi Medical University, Nanning 530021, Guangxi Zhuang Autonomous Region, People's Republic of China
| | - Y T Peng
- Department of Medical Ultrasonics, First Affiliated Hospital of Guangxi Medical University, Nanning 530021, Guangxi Zhuang Autonomous Region, People's Republic of China
| | - P Lin
- Department of Medical Ultrasonics, First Affiliated Hospital of Guangxi Medical University, Nanning 530021, Guangxi Zhuang Autonomous Region, People's Republic of China
| | - D Wan
- Department of Medical Ultrasonics, First Affiliated Hospital of Guangxi Medical University, Nanning 530021, Guangxi Zhuang Autonomous Region, People's Republic of China
| | - H Qin
- Department of Medical Ultrasonics, First Affiliated Hospital of Guangxi Medical University, Nanning 530021, Guangxi Zhuang Autonomous Region, People's Republic of China
| | - X Li
- GE HealthcareShanghai, People's Republic of China
| | - X R Wang
- GE HealthcareShanghai, People's Republic of China
| | - Y He
- Department of Medical Ultrasonics, First Affiliated Hospital of Guangxi Medical University, Nanning 530021, Guangxi Zhuang Autonomous Region, People's Republic of China.
| | - H Yang
- Department of Medical Ultrasonics, First Affiliated Hospital of Guangxi Medical University, Nanning 530021, Guangxi Zhuang Autonomous Region, People's Republic of China.
| |
Collapse
|
19
|
Barman A, Gubbiotti G, Ladak S, Adeyeye AO, Krawczyk M, Gräfe J, Adelmann C, Cotofana S, Naeemi A, Vasyuchka VI, Hillebrands B, Nikitov SA, Yu H, Grundler D, Sadovnikov AV, Grachev AA, Sheshukova SE, Duquesne JY, Marangolo M, Csaba G, Porod W, Demidov VE, Urazhdin S, Demokritov SO, Albisetti E, Petti D, Bertacco R, Schultheiss H, Kruglyak VV, Poimanov VD, Sahoo S, Sinha J, Yang H, Münzenberg M, Moriyama T, Mizukami S, Landeros P, Gallardo RA, Carlotti G, Kim JV, Stamps RL, Camley RE, Rana B, Otani Y, Yu W, Yu T, Bauer GEW, Back C, Uhrig GS, Dobrovolskiy OV, Budinska B, Qin H, van Dijken S, Chumak AV, Khitun A, Nikonov DE, Young IA, Zingsem BW, Winklhofer M. The 2021 Magnonics Roadmap. J Phys Condens Matter 2021; 33:413001. [PMID: 33662946 DOI: 10.1088/1361-648x/abec1a] [Citation(s) in RCA: 50] [Impact Index Per Article: 16.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Subscribe] [Scholar Register] [Received: 08/14/2020] [Accepted: 03/04/2021] [Indexed: 05/26/2023]
Abstract
Magnonics is a budding research field in nanomagnetism and nanoscience that addresses the use of spin waves (magnons) to transmit, store, and process information. The rapid advancements of this field during last one decade in terms of upsurge in research papers, review articles, citations, proposals of devices as well as introduction of new sub-topics prompted us to present the first roadmap on magnonics. This is a collection of 22 sections written by leading experts in this field who review and discuss the current status besides presenting their vision of future perspectives. Today, the principal challenges in applied magnonics are the excitation of sub-100 nm wavelength magnons, their manipulation on the nanoscale and the creation of sub-micrometre devices using low-Gilbert damping magnetic materials and its interconnections to standard electronics. To this end, magnonics offers lower energy consumption, easier integrability and compatibility with CMOS structure, reprogrammability, shorter wavelength, smaller device features, anisotropic properties, negative group velocity, non-reciprocity and efficient tunability by various external stimuli to name a few. Hence, despite being a young research field, magnonics has come a long way since its early inception. This roadmap asserts a milestone for future emerging research directions in magnonics, and hopefully, it will inspire a series of exciting new articles on the same topic in the coming years.
Collapse
Affiliation(s)
- Anjan Barman
- Department of Condensed Matter Physics and Material Sciences, S N Bose National Centre for Basic Sciences, Salt Lake, Kolkata 700106, India
| | - Gianluca Gubbiotti
- Istituto Officina dei Materiali del Consiglio nazionale delle Ricerche (IOM-CNR), Perugia, Italy
| | - S Ladak
- School of Physics and Astronomy, Cardiff University, United Kingdom
| | - A O Adeyeye
- Department of Physics, University of Durham, United Kingdom
| | - M Krawczyk
- Adam Mickiewicz University, Poznan, Poland
| | - J Gräfe
- Max Planck Institute for Intelligent Systems, Stuttgart, Germany
| | | | - S Cotofana
- Delft University of Technology, The Netherlands
| | - A Naeemi
- Georgia Institute of Technology, United States of America
| | - V I Vasyuchka
- Department of Physics and State Research Center OPTIMAS, Technische Universität Kaiserslautern (TUK), Kaiserslautern, Germany
| | - B Hillebrands
- Department of Physics and State Research Center OPTIMAS, Technische Universität Kaiserslautern (TUK), Kaiserslautern, Germany
| | - S A Nikitov
- Kotelnikov Institute of Radioengineering and Electronics, Moscow, Russia
| | - H Yu
- Fert Beijing Institute, BDBC, School of Microelectronics, Beijing Advanced Innovation Center for Big Data and Brian Computing, Beihang University, People's Republic of China
| | - D Grundler
- Laboratory of Nanoscale Magnetic Materials and Magnonics, Institute of Materials (IMX), Institute of Electrical and Micro Engineering, School of Engineering, École Polytechnique Fédérale de Lausanne (EPFL), Switzerland
| | - A V Sadovnikov
- Kotelnikov Institute of Radioengineering and Electronics, Moscow, Russia
- Laboratory 'Magnetic Metamaterials', Saratov State University, Saratov, Russia
| | - A A Grachev
- Kotelnikov Institute of Radioengineering and Electronics, Moscow, Russia
- Laboratory 'Magnetic Metamaterials', Saratov State University, Saratov, Russia
| | - S E Sheshukova
- Kotelnikov Institute of Radioengineering and Electronics, Moscow, Russia
- Laboratory 'Magnetic Metamaterials', Saratov State University, Saratov, Russia
| | - J-Y Duquesne
- Institut des NanoSciences de Paris, Sorbonne University, CNRS, Paris, France
| | - M Marangolo
- Institut des NanoSciences de Paris, Sorbonne University, CNRS, Paris, France
| | - G Csaba
- Pázmány University, Budapest, Hungary
| | - W Porod
- University of Notre Dame, IN, United States of America
| | - V E Demidov
- Institute for Applied Physics, University of Muenster, Muenster, Germany
| | - S Urazhdin
- Department of Physics, Emory University, Atlanta, United States of America
| | - S O Demokritov
- Institute for Applied Physics, University of Muenster, Muenster, Germany
| | | | - D Petti
- Polytechnic University of Milan, Italy
| | | | - H Schultheiss
- Helmholtz-Center Dresden-Rossendorf, Institute of Ion Beam Physics and Materials Research, Germany
- Technische Universität Dresden, Germany
| | | | | | - S Sahoo
- Department of Condensed Matter Physics and Material Sciences, S N Bose National Centre for Basic Sciences, Salt Lake, Kolkata 700106, India
| | - J Sinha
- Department of Physics and Nanotechnology, SRM Institute of Science and Technology, Kattankulathur, India
| | - H Yang
- Department of Electrical and Computer Engineering, National University of Singapore, Singapore
| | - M Münzenberg
- Institute of Physics, University of Greifswald, Greifswald, Germany
| | - T Moriyama
- Institute for Chemical Research, Kyoto University, Gokasho, Uji, Kyoto, Japan
- Centre for Spintronics Research Network, Japan
| | - S Mizukami
- Centre for Spintronics Research Network, Japan
- Advanced Institute for Materials Research (WPI-AIMR), Tohoku University, Sendai, Japan
| | - P Landeros
- Departamento de Física, Universidad Técnica Federico Santa María, Valparaíso, Chile
- Center for the Development of Nanoscience and Nanotechnology (CEDENNA), Santiago, Chile
| | - R A Gallardo
- Departamento de Física, Universidad Técnica Federico Santa María, Valparaíso, Chile
- Center for the Development of Nanoscience and Nanotechnology (CEDENNA), Santiago, Chile
| | - G Carlotti
- Dipartimento di Fisica e Geologia, University of Perugia, Perugia, Italy
- CNR Instituto Nanoscienze, Modena, Italy
| | - J-V Kim
- Centre for Nanosciences and Nanotechnology, CNRS, Université Paris-Saclay, Palaiseau, France
| | - R L Stamps
- Department of Physics and Astronomy, University of Manitoba, Canada
| | - R E Camley
- Center for Magnetism and Magnetic Nanostructures, University of Colorado, Colorado Springs, United States of America
| | | | - Y Otani
- RIKEN, Japan
- Institute for Solid State Physics (ISSP), University of Tokyo, Japan
| | - W Yu
- Institute for Materials Research, Tohoku University, Sendai, 980-8577, Japan
| | - T Yu
- Max Planck Institute for the Structure and Dynamics of Matter, Hamburg, Germany
| | - G E W Bauer
- Advanced Institute for Materials Research (WPI-AIMR), Tohoku University, Sendai, Japan
- Zernike Institute for Advanced Materials, Groningen University, The Netherlands
| | - C Back
- Technical University Munich, Germany
| | - G S Uhrig
- Technical University Dortmund, Germany
| | | | - B Budinska
- Faculty of Physics, University of Vienna, Vienna, Austria
| | - H Qin
- Department of Applied Physics, School of Science, Aalto University, Finland
| | - S van Dijken
- Department of Applied Physics, School of Science, Aalto University, Finland
| | - A V Chumak
- Faculty of Physics, University of Vienna, Vienna, Austria
| | - A Khitun
- University of California Riverside, United States of America
| | - D E Nikonov
- Components Research, Intel, Hillsboro, Oregon, United States of America
| | - I A Young
- Components Research, Intel, Hillsboro, Oregon, United States of America
| | - B W Zingsem
- The University of Duisburg-Essen, CENIDE, Germany
| | - M Winklhofer
- The Carl von Ossietzky University of Oldenburg, Germany
| |
Collapse
|
20
|
Han C, Meng XC, Sun C, Dong C, Zheng WP, Wang K, Qin H, Yang Y, Zhang FB, Xu M, Cao SQ, Gao W. [Risk factors of blood loss during liver transplantation in children with biliary atresia and its influence on prognosis]. Zhonghua Wai Ke Za Zhi 2021; 59:491-496. [PMID: 34102733 DOI: 10.3760/cma.j.cn112139-20200810-00626] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Subscribe] [Scholar Register] [Indexed: 11/05/2022]
Abstract
Objectives: To study the risk factors for massive intraoperative blood loss in children with biliary atresia who underwent liver transplantation for the first time,and to analyze their impacts on graft survival,hospital stay and postoperative complications. Methods: The data of 613 children with biliary atresia who underwent liver transplantation at Department of Pediatric Organ Transplantation,Tianjin First Central Hospital from January 2015 to December 2018 were collected and analyzed. There were 270 males and 343 females, aged 7.4 (3.9) months (range: 3.2 to 148.4 months), the body weight of the recipients were (7.8±3.5) kg (range: 4.0 to 43.3 kg).According to the 85th quad of estimated blood loss(EBL),they were divided into two groups:massive EBL group(96 cases) and non massive EBL group(517 cases). The age,height,weight and other factors between the two groups were analyzed and compared. Univariate Logistic regression and multiple stepwise regression were used to determine the risk factors of massive EBL. Then,the postoperative complications of the two groups,including portal vein thrombosis and portal vein anastomotic stenosis etc.,were analyzed and compared by chi square test. Kaplan Meier curve and log rank test were used to analyze the recipient and graft survival rate of the two groups. Results: During the study period,713 transplants were performed and 613 patients were enrolled in the study. Ninety-six patients(15.7%) had massive EBL,and the postoperative hospital stay was 21(16) days(range:2 to 116 days),the hospital stay of non-massive EBL group was 22(12)days(range:3 to 138 days)(U=24 224.0,P=0.32). Univariate Logistic regression analysis showed that the recipient's weight,Kasai portoenterostomy,platelet count,operation time and cold ischemia time were the risk factors of massive EBL during biliary atresia transplantation. Multiple regression analysis showed that cold ischemia time ≥10 hours,prolonged operation time(≥8 hours) and body weight<5.5 kg were important independent risk factors for massive EBL.The incidence of portal vein thrombosis,hepatic vein stenosis,intestinal leakage and pulmonary infection in patients with massive EBL were significantly higher than those without massive EBL(3.1% vs. 0.8%,9.4% vs. 2.1%,6.3% vs. 0.8%,30.2% vs. 20.1%,all P<0.05). The 3-year overall graft and recipient survival rate were significantly lower in patients with massive EBL than those without massive EBL(87.5% vs. 95.7%,P=0.001;84.4% vs. 95.4%,P<0.01,respectively). Conclusions: In children with biliary atresia who underwent liver transplantation for the first time,the effective control of intraoperative bleeding should shorten the operation time and reduce the cold ischemia time as far as possible,on the premise of ensuring the safety of operation. For children without growth disorder,the weight of children should be increased to more than 5.5 kg as far as possible to receive the operation. Reducing intraoperative bleeding is of great significance to the prognosis of children.
Collapse
Affiliation(s)
- C Han
- Department of Pediatric Organ Transplantation,Tianjin First Central Hospital,Tianjin 300192,China
| | - X C Meng
- Department of Pediatric Organ Transplantation,Tianjin First Central Hospital,Tianjin 300192,China
| | - C Sun
- Department of Pediatric Organ Transplantation,Tianjin First Central Hospital,Tianjin 300192,China
| | - C Dong
- Department of Pediatric Organ Transplantation,Tianjin First Central Hospital,Tianjin 300192,China
| | - W P Zheng
- Department of Pediatric Organ Transplantation,Tianjin First Central Hospital,Tianjin 300192,China
| | - K Wang
- Department of Pediatric Organ Transplantation,Tianjin First Central Hospital,Tianjin 300192,China
| | - H Qin
- Department of Pediatric Organ Transplantation,Tianjin First Central Hospital,Tianjin 300192,China
| | - Y Yang
- Department of Pediatric Organ Transplantation,Tianjin First Central Hospital,Tianjin 300192,China
| | - F B Zhang
- Department of Pediatric Organ Transplantation,Tianjin First Central Hospital,Tianjin 300192,China
| | - M Xu
- Department of Pediatric Organ Transplantation,Tianjin First Central Hospital,Tianjin 300192,China
| | - S Q Cao
- Department of Pediatric Organ Transplantation,Tianjin First Central Hospital,Tianjin 300192,China
| | - W Gao
- Department of Pediatric Organ Transplantation,Tianjin First Central Hospital,Tianjin 300192,China
| |
Collapse
|
21
|
Qin H, Liu J, Du ZH, Hu R, Yu YK, Wang QA. Circular RNA hsa_circ_0012673 facilitates lung cancer cell proliferation and invasion via miR-320a/LIMK18521 axis. Eur Rev Med Pharmacol Sci 2021; 24:1841-1852. [PMID: 32141553 DOI: 10.26355/eurrev_202002_20362] [Citation(s) in RCA: 11] [Impact Index Per Article: 3.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Subscribe] [Scholar Register] [Indexed: 11/12/2022]
Abstract
OBJECTIVE Lung cancer is one of the most malignant tumors with high morbidity and mortality in the world. The incidence and mortality of lung cancer were increased per year in many countries over the past 50 years. The increasing studies had shown that circular RNA (circRNA) was involved in the progression of lung cancer. Therefore, it was significant to seek the molecular mechanism of circ_0012673 in lung cancer. MATERIALS AND METHODS Real-time quantitative polymerase chain reaction (RT-qPCR) was performed to estimate the expression levels of circ_0012673, miR-320a and LIM domain kinase 1 (LIMK1) in lung cancer tissues and cells. 3-(4, 5-dimethylthiazol-2-yl)-2,5-diphenyl-2H-tetrazol-3-ium bromide (MTT), flow cytometry and transwell assays were recruited to evaluate proliferation, apoptosis and mobility of lung cancer cells, respectively. The relative protein expression levels of Vimentin, N-cadherin, E-cadherin and LIMK1 were determined with Western blot assay. The relationships among circ_0012673, miR-320a and LIMK1 were analyzed by starBase database, dual-luciferase reporter assay, and Pearson's correlation. RESULTS Circ_0012673 was overexpressed in lung cancer tissues and cell lines. Loss-of-functional experiment confirmed that knockdown of circ_0012673 constrained proliferation, motility and Epithelial-Mesenchymal Transition (EMT), but induced apoptosis by targeting miR-320a. Furthermore, LIMK1 was a target of miR-320a in lung cancer cells. Elevated LIMK1 could abolish the overexpression of miR-320a induced effects on lung cancer cells. Mechanistically, circ_0012673 contributed to lung cancer progression through mediating miR-320a /LIMK1 pathway. CONCLUSIONS Circ_0012673 was a tumor-promoter in lung cancer via acting as competing endogenous RNA to regulate LIMK1 expression by binding miR-320a.
Collapse
Affiliation(s)
- H Qin
- Department of Thoracic Surgery, Shengli Oilfield Central Hospital, Dongying, Shandong, China.
| | | | | | | | | | | |
Collapse
|
22
|
Su Y, Ma XL, Wang HM, Qin H, Qin MQ, Zhang FQ, Jin M, Zhang DW, Chen CH, Zeng Q, He LJ, Ni X. [Clinical characteristics and prognostic analysis of 458 children with high-risk neuroblastoma in a single center]. Zhonghua Er Ke Za Zhi 2020; 58:796-801. [PMID: 32987457 DOI: 10.3760/cma.j.cn112140-20200525-00540] [Citation(s) in RCA: 5] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Subscribe] [Scholar Register] [Indexed: 11/05/2022]
Abstract
Objective: To summarize the clinical characteristics of high-risk neuroblastoma (HR-NB) in a single center, analyze the prognostic factors of HR-NB. Methods: The clinical data of children with HR-NB who were treated and followed up at the hematology-oncology center of Beijing Children's Hospital from February 1, 2007 to June 30, 2018 were analyzed retrospectively. The clinical features were summarized. Kaplan-Meier method was used for survival analysis and Cox regression was used to analyze the prognostic factors. The last follow-up time was June 30, 2019. Results: A total of 458 children with HR-NB were enrolled in this study, including 265 males (57.9%) and 193 females (42.1%), the age at diagnosis was 40.0 months (4.5-148.0 months), the follow-up time was 22.0 months (0.2-138.0 months) and the time of tumor progression or recurrence was 15 months (1-72 months). The 5-year event-free survival (EFS) rate was (31.2±2.6)% and the 5-year overall survival (OS) rate was (43.9±3.2)%. The 5-year EFS rate and 5-year OS rate in 142 hematopoietic stem cell transplantation (HSCT) patients with bone marrow metastases were better than that in 196 non-transplantation cases with bone marrow metastases ((26.5±4.5)% vs. (25.1±3.6)%, χ²=13.773, P=0.001; (38.1±5.5)% vs. (35.7±4.7)%, χ²=9.235, P=0.002); 128 transplantation patients with bone metastases had higher 5-year EFS rate and 5-year OS rate than 188 non-transplantation cases with bone metastases ((28.5±5.0)% vs. (26.7±3.8)%, χ²=10.222, P=0.001; (37.1±6.0)% vs. (36.2±4.8)%, χ²=7.843, P=0.005). The 5-year EFS rate was higher in 37 HSCT patients with MYCN amplification than in 49 non-transplantation cases with MYCN amplification ((26.8±8.0) % vs. (20.5±6.4) %, χ²=5.732, P=0.017). No significant difference was found in 5-years OS rate between transplantation group with MYCN amplification and non-transplantation group with MYCN amplification ((31.4±8.6) % vs. (26.2±7.4) %, χ²=3.230, P=0.072). Univariate survival analysis showed that lactate dehydrogenase (LDH)≥1 500 U/L was associated with poor prognosis of patients with MYCN amplification (χ²=6.960, P=0.008). Multivariate Cox analysis showed bone marrow metastasis and LDH≥1 500 U/L were independent risk factors for poor prognosis of patients with non-MYCN amplification (HR=2.427, 1.618;95%CI:1.427-4.126, 1.275-2.054, P<0.05) for both comparisons. Conclusions: LDH≥1 500 U/L was the poor prognostic factor for patients with MYCN amplification. The bone marrow metastasis and LDH≥1 500 U/L were the poor prognostic factors for HR-NB patients with non-MYCN amplification. HSCT can improve the prognosis of patients with bone or bone marrow metastasis. It can also retard the time of progression or recurrence for patients with MYCN amplification.
Collapse
Affiliation(s)
- Y Su
- Hematology Oncology Center, Beijing Children's Hospital, Capital Medical University, National Center for Children's Health, Beijing Key Laboratory of Pediatric Hematology Oncology, National Key Discipline of Pediatrics, Ministry of Education, Key Laboratory of Major Diseases in Children, Beijing 100045, China
| | - X L Ma
- Hematology Oncology Center, Beijing Children's Hospital, Capital Medical University, National Center for Children's Health, Beijing Key Laboratory of Pediatric Hematology Oncology, National Key Discipline of Pediatrics, Ministry of Education, Key Laboratory of Major Diseases in Children, Beijing 100045, China
| | - H M Wang
- Department of Surgical Oncology, Beijing Children's Hospital, Capital Medical University, National Center for Children's Health, Beijing 100045, China
| | - H Qin
- Department of Surgical Oncology, Beijing Children's Hospital, Capital Medical University, National Center for Children's Health, Beijing 100045, China
| | - M Q Qin
- Hematology Oncology Center, Beijing Children's Hospital, Capital Medical University, National Center for Children's Health, Beijing Key Laboratory of Pediatric Hematology Oncology, National Key Discipline of Pediatrics, Ministry of Education, Key Laboratory of Major Diseases in Children, Beijing 100045, China
| | - F Q Zhang
- Department of Radiation Oncology, Beijing Union Hospital, Chinese Academy of Medical Sciences, Beijing 100730, China
| | - M Jin
- Hematology Oncology Center, Beijing Children's Hospital, Capital Medical University, National Center for Children's Health, Beijing Key Laboratory of Pediatric Hematology Oncology, National Key Discipline of Pediatrics, Ministry of Education, Key Laboratory of Major Diseases in Children, Beijing 100045, China
| | - D W Zhang
- Hematology Oncology Center, Beijing Children's Hospital, Capital Medical University, National Center for Children's Health, Beijing Key Laboratory of Pediatric Hematology Oncology, National Key Discipline of Pediatrics, Ministry of Education, Key Laboratory of Major Diseases in Children, Beijing 100045, China
| | - C H Chen
- Department of Thoracic Surgery, Beijing Children's Hospital, Capital Medical University, National Center for Children's Health, Beijing 10005, China
| | - Q Zeng
- Department of Thoracic Surgery, Beijing Children's Hospital, Capital Medical University, National Center for Children's Health, Beijing 10005, China
| | - L J He
- Department of Pathology, Beijing Children's Hospital, Capital Medical University, National Center for Children's Health, Beijing 10004, China
| | - X Ni
- Department of Otorhinolaryngology Head and Neck Surgery, Beijing Children's Hospital, Capital Medical University, National Center for Children's Health, Beijing 100045, China
| |
Collapse
|
23
|
Qin H, Wang F, Zeng Z, Gao H. 409P Effect of transdermal granisetron on prevention of nausea and vomiting during chemotherapy of lung cancer. Ann Oncol 2020. [DOI: 10.1016/j.annonc.2020.10.403] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/22/2022] Open
|
24
|
Deng X, Yang G, Zheng X, Yang Y, Qin H, Liu ZX, Deng H, Liu SM. Plasma mtDNA copy numbers are associated with GSTK1 expression and inflammation in type 2 diabetes. Diabet Med 2020; 37:1874-1878. [PMID: 31502701 DOI: 10.1111/dme.14132] [Citation(s) in RCA: 12] [Impact Index Per Article: 3.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Accepted: 09/05/2019] [Indexed: 01/23/2023]
Abstract
AIMS Mitochondrial dysfunction is involved in the pathogenesis of type 2 diabetes. Glutathione S-transferase kappa 1 (GSTK1) is critical to maintain mitochondrial function and homeostasis. We aimed to investigate whether a potential link exists between mitochondrial DNA (mtDNA) copy numbers and inflammation, non-esterified fatty acids (NEFA) and GSTK1 expression in type 2 diabetes. METHODS We assessed mtDNA copy numbers in plasma and GSTK1 expression in white blood cells in 123 people with type 2 diabetes and in 121 healthy controls using a quantitative polymerase chain reaction (qPCR). An automatic chemistry or immunoassay analyser was used to determine serum glucose, lipids and inflammatory markers. Multiple linear regression and multivariable logistic regression models were used to evaluate associations and risks. RESULTS Compared with healthy controls, individuals with diabetes showed higher mtDNA copy numbers (t = -3.938, P < 0.001) and lower GSTK1 expression (Z = -2.985, P = 0.002). mtDNA copy number was associated with type 2 diabetes risk [odds ratio (OR) = 1.80, 95% confidence intervals (CI) 1.25-2.58, P = 0.001] after controlling for confounding factors. In individuals with diabetes, mtDNA copy number was negatively associated with GSTK1 expression (β = -0.235, P = 0.036) and positively associated with serum high-sensitive C-reactive protein (hsCRP) (β = 0.839, P < 0.001), tumour necrosis factor alpha (TNF-α) (β = 0.549, P < 0.001), interleukin-6 (IL-6) (β = 0.589, P = 0.006) and NEFA (β = 0.001, P = 0.020). In the diabetic group, individuals with an abnormal increase in NEFA, hsCRP, TNF-α and IL-6 showed significantly elevated mtDNA copy numbers (all P < 0.05). CONCLUSIONS mtDNA copy numbers in plasma might have an important role in the progression of diabetic chronic inflammation via inhibition of GSTK1 and could be a potential biomarker for type 2 diabetes.
Collapse
Affiliation(s)
- X Deng
- Department of Clinical Laboratory, Center for Gene Diagnosis & Program of Clinical Laboratory, Wuhan, China
| | - G Yang
- Department of Clinical Laboratory, Center for Gene Diagnosis & Program of Clinical Laboratory, Wuhan, China
| | - X Zheng
- Laboratory of Molecular Cardiology, Wuhan Asia Heart Hospital, Wuhan University, Wuhan, China
| | - Y Yang
- Department of Clinical Laboratory, Center for Gene Diagnosis & Program of Clinical Laboratory, Wuhan, China
| | - H Qin
- Department of Pharmaceutical Sciences, School of Pharmaceutical Sciences, Hubei Polytechnic University, Guilin, China
| | - Z-X Liu
- Department of Clinical Laboratory, Center for Gene Diagnosis & Program of Clinical Laboratory, Wuhan, China
| | - H Deng
- Department of Endocrinology, Zhongnan Hospital of Wuhan University, Wuhan, China
| | - S-M Liu
- Department of Clinical Laboratory, Center for Gene Diagnosis & Program of Clinical Laboratory, Wuhan, China
| |
Collapse
|
25
|
Qin H, Wang F, Wang S, Zeng Z, Gao H. 1804P The efficacy of apatinib plus topotecan as laterline therapy for advanced small cell lung cancer. Ann Oncol 2020. [DOI: 10.1016/j.annonc.2020.08.1565] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/26/2022] Open
|
26
|
Yan SB, Qin H, Liu WL, Luo RZ. [Cervical giant neuroblastoma in an infant: a case report]. Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi 2020; 55:790-792. [PMID: 32791781 DOI: 10.3760/cma.j.cn115330-20200304-00161] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 06/11/2023]
Affiliation(s)
- S B Yan
- Department of Otolaryngology, Guangzhou Women and Children's Medical Center, Guangzhou Medical University, Guangzhou 510623, China
| | - H Qin
- Department of Otolaryngology, Guangzhou Women and Children's Medical Center, Guangzhou Medical University, Guangzhou 510623, China
| | - W L Liu
- Department of Otolaryngology, Guangzhou Women and Children's Medical Center, Guangzhou Medical University, Guangzhou 510623, China
| | - R Z Luo
- Department of Otolaryngology, Guangzhou Women and Children's Medical Center, Guangzhou Medical University, Guangzhou 510623, China
| |
Collapse
|
27
|
Cheng X, Redanz S, Treerat P, Qin H, Choi D, Zhou X, Xu X, Merritt J, Kreth J. Magnesium-Dependent Promotion of H 2O 2 Production Increases Ecological Competitiveness of Oral Commensal Streptococci. J Dent Res 2020; 99:847-854. [PMID: 32197054 PMCID: PMC7313347 DOI: 10.1177/0022034520912181] [Citation(s) in RCA: 14] [Impact Index Per Article: 3.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/05/2023] Open
Abstract
The pyruvate oxidase (SpxB)-dependent production of H2O2 is widely distributed among oral commensal streptococci. Several studies confirmed the ability of H2O2 to antagonize susceptible oral bacterial species, including caries-associated Streptococcus mutans as well as several periodontal pathobionts. Here we report a potential mechanism to bolster oral commensal streptococcal H2O2 production by magnesium (Mg2+) supplementation. Magnesium is a cofactor for SpxB catalytic activity, and supplementation increases the production of H2O2 in vitro. We demonstrate that Mg2+ affects spxB transcription and SpxB abundance in Streptococcus sanguinis and Streptococcus gordonii. The competitiveness of low-passage commensal streptococcal clinical isolates is positively influenced in antagonism assays against S. mutans. In growth conditions normally selective for S. mutans, Mg2+ supplementation is able to increase the abundance of S. sanguinis in dual-species biofilms. Using an in vivo biophotonic imaging platform, we further demonstrate that dietary Mg2+ supplementation significantly improves S. gordonii oral colonization in mice. In summary, our results support a role for Mg2+ supplementation as a potential prebiotic to promote establishment of oral health-associated commensal streptococci.
Collapse
Affiliation(s)
- X. Cheng
- The State Key Laboratory of Oral Diseases & National Clinical Research Center for Oral Diseases, West China Hospital of Stomatology, Sichuan University, Chengdu, China,Department of Geriatric Dentistry, West China Hospital of Stomatology, Sichuan University, Chengdu, China
| | - S. Redanz
- Department of Molecular Microbiology and Immunology, Oregon Health and Science University, Portland, OR, USA
| | - P. Treerat
- Department of Molecular Microbiology and Immunology, Oregon Health and Science University, Portland, OR, USA
| | - H. Qin
- Department of Molecular Microbiology and Immunology, Oregon Health and Science University, Portland, OR, USA
| | - D. Choi
- Department of Community Dentistry, School of Dentistry, Oregon Health & Science University, Portland, OR, USA,School of Public Health, Oregon Health & Science University, Portland, OR, USA
| | - X. Zhou
- The State Key Laboratory of Oral Diseases & National Clinical Research Center for Oral Diseases, West China Hospital of Stomatology, Sichuan University, Chengdu, China,Department of Cariology and Endodontics, West China Hospital of Stomatology, Sichuan University, Chengdu, China
| | - X. Xu
- The State Key Laboratory of Oral Diseases & National Clinical Research Center for Oral Diseases, West China Hospital of Stomatology, Sichuan University, Chengdu, China,Department of Cariology and Endodontics, West China Hospital of Stomatology, Sichuan University, Chengdu, China
| | - J. Merritt
- Department of Molecular Microbiology and Immunology, Oregon Health and Science University, Portland, OR, USA,Department of Restorative Dentistry, Oregon Health and Science University, Portland, OR, USA
| | - J. Kreth
- Department of Molecular Microbiology and Immunology, Oregon Health and Science University, Portland, OR, USA,Department of Restorative Dentistry, Oregon Health and Science University, Portland, OR, USA,J. Kreth, Oregon Health and Science University, 3181 SW Sam Jackson Park Rd., MRB433, Portland, OR 97239, USA.
| |
Collapse
|
28
|
Qin H, Yang Y, Zhao X, Qiu X, Guo H. SOX9 in prostate cancer is upregulated by cancer-associated fibroblasts to mediate the tumor-promoting effects through HGF/c-Met-ERK1/2-FRA1 signaling. EUR UROL SUPPL 2020. [DOI: 10.1016/s2666-1683(20)33824-6] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022] Open
|
29
|
Jiang B, Chen W, Qin H, Zhao X, Guo H. TOX High Mobility Group Box Family Member 3 suppresses epithelial-mesenchymal transition in clear cell renal cell carcinoma by transcriptionally regulating SNAI1 and SNAI2. EUR UROL SUPPL 2020. [DOI: 10.1016/s2666-1683(20)33587-4] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/23/2022] Open
|
30
|
Hou W, Qiu P, Chen NJ, Yao P, Liu S, Qin H. [Study on the role and possible mechanism of hemeoxygenase-1/carbon monoxide system in protection of quercetin against ethanol-induced hepatocytes oxidative injury]. Zhonghua Gan Zang Bing Za Zhi 2020; 28:504-508. [PMID: 32660180 DOI: 10.3760/cma.j.cn501113-20200522-00269] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Subscribe] [Scholar Register] [Indexed: 11/05/2022]
Abstract
Objective: To study the protective effect and potential mechanism of heme oxygenase (HO-1)/carbon monoxide (CO)-mediated quercetin on alcoholic oxidative damage of primary rat hepatocytes. Methods: Primary rat hepatocytes were isolated and cultured by two-step collagenase technique. Ethanol exposed primary rat hepatocytes were simultaneously added with quercetin (100 μmol/L) and/or hemoglobin (100 μmol/L) or different doses of CO-releasing molecules (CORM-2, 5-50 μmol/L) for their combined action. After polling, LDH, AST activities and MDA and GSH levels were measured in the supernatant of cell culture. The alone or combined effects of quercetin, CORM-2, hemoglobin and zinc protoporphyrin IX exposed to ethanol were detected by the activity of CYP2E1 in liver microsomes. Statistical analysis of data was performed by analysis of variance (ANOVA) and intergroup comparison was done by SNK-test. Results: Simultaneous addition of 100 μmol/L quercetin had significantly reduced ethanol-induced AST and LDH release, and GSH consumption and MDA elevation extent. Moreover, quercetin had not only lost the hemoglobin (CO blocker) protective effect but also had further exacerbated ethanol-induced lipid peroxidation. CORM-2 had reduced ethanol-induced AST and LDH release, and GSH consumption and MDA production in liver cells, and thus had dose-dependent protective effect. Ethanol had increased significantly CYP2E1 activity. Quercetin or CORM-2 had inhibited CYP2E1 activity, while hemoglobin or protoporphyrin IX had eliminated quercetin inhibitory effect and had increased the CYP2E1 activity. Quercetin, and CYP2E1 activity was constant as compared to ethanol group when CORM-2, zinc protoporphyrin IX and ethanol were incubated with hepatocytes, but the CYP2E1 activity was significantly decreased (P < 0.05), and the differences were statistically significant. Conclusion: CO/HO-1 metabolite mediates the protective effect of quercetin on alcoholic oxidative damage of hepatocytes, which may be related to the inhibition of CYP2E1 activity.
Collapse
Affiliation(s)
- W Hou
- Department of Gastroenterology, Tongji Hospital of Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, China
| | - P Qiu
- Department of Gastroenterology, Tongji Hospital of Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, China
| | - N J Chen
- Department of Gastroenterology, Tongji Hospital of Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, China
| | - P Yao
- Department of Nutrition and Food Hygiene, School of Public Health, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, China
| | - S Liu
- Institute of Health Surveillance, Analysis and Protection, Hubei Center for Disease Control and Prevention , Wuhan 430079, China
| | - H Qin
- Department of Gastroenterology, Tongji Hospital of Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, China
| |
Collapse
|
31
|
Lin P, Liu WK, Li X, Wan D, Qin H, Li Q, Chen G, He Y, Yang H. MRI-based radiogenomics analysis for predicting genetic alterations in oncogenic signalling pathways in invasive breast carcinoma. Clin Radiol 2020; 75:561.e1-561.e11. [PMID: 32183997 DOI: 10.1016/j.crad.2020.02.011] [Citation(s) in RCA: 11] [Impact Index Per Article: 2.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/18/2019] [Accepted: 02/18/2020] [Indexed: 01/23/2023]
Abstract
AIM To investigate the effect of radiomics in the assessment of alterations in canonical cancer pathways in breast cancer. MATERIALS AND METHODS Eighty-eight biopsy-proven breast cancer cases were included in the present study. Radiomics features were extracted from T1-weighted sagittal dynamic contrast-enhanced magnetic resonance imaging (MRI) images. Radiomics signatures were developed to predict genetic alterations in the cell cycle, Myc, PI3K, RTK/RAS, and p53 signalling pathways by using hypothesis testing combined with least absolute shrinkage and selection operator (LASSO) regression analysis. The predictive powers of the models were examined by the area under the curve (AUC) of the receiver operating characteristic curve. RESULTS A total of 5,234 radiomics features were obtained from MRI images based on the tumour region of interest. Hypothesis tests screened 250, 229, 156, 785, and 319 radiomics features that were differentially displayed between cell cycle, Myc, PI3K, RTK/RAS, and p53 alterations and no alteration status. According to the LASSO algorithm, 11, 12, 12, 15, and 13 features were identified for the construction of the radiomics signatures to predict cell cycle, Myc, PI3K, RTK/RAS, and p53 alterations, with AUC values of 0.933, 0.926, 0.956, 0.940, and 0.886, respectively. The cell cycle radiomics score correlated closely with the RTK/RAS and p53 radiomics scores. These signatures were also dysregulated in patients with different oestrogen receptor, progesterone receptor, and human epidermal growth factor receptor 2 statuses. CONCLUSION MRI-based radiogenomics analysis exhibits excellent performance in predicting genetic pathways alterations, thus providing a novel approach for non-invasively obtaining genetic-level molecular characteristics of tumours.
Collapse
Affiliation(s)
- P Lin
- Department of Ultrasound, First Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi Zhuang Autonomous Region 530021, China
| | - W K Liu
- Department of Ultrasound, Affiliated Union Hospital of Fujian Medical University, Fuzhou, Fu Jian 350000, China
| | - X Li
- GE Healthcare, Shanghai, China
| | - D Wan
- Department of Ultrasound, First Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi Zhuang Autonomous Region 530021, China
| | - H Qin
- Department of Ultrasound, First Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi Zhuang Autonomous Region 530021, China
| | - Q Li
- Department of Ultrasound, First Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi Zhuang Autonomous Region 530021, China
| | - G Chen
- Department of Pathology, First Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi Zhuang Autonomous Region 530021, China
| | - Y He
- Department of Ultrasound, First Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi Zhuang Autonomous Region 530021, China
| | - H Yang
- Department of Ultrasound, First Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi Zhuang Autonomous Region 530021, China.
| |
Collapse
|
32
|
Chen Z, Chen G, Qin H, Cai Z, Huang J, Chen H, Wu W, Chen Z, Wu S, Chen Y. Higher triglyceride to high-density lipoprotein cholesterol ratio increases cardiovascular risk: 10-year prospective study in a cohort of Chinese adults. J Diabetes Investig 2020; 11:475-481. [PMID: 31325411 PMCID: PMC7078082 DOI: 10.1111/jdi.13118] [Citation(s) in RCA: 24] [Impact Index Per Article: 6.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 03/23/2019] [Revised: 07/16/2019] [Accepted: 07/18/2019] [Indexed: 02/05/2023] Open
Abstract
AIMS/INTRODUCTION A higher ratio of triglyceride to high-density lipoprotein cholesterol (TG/HDL-C) is considered as the independent risk index of cardiovascular (CV) events. However, cohort studies regarding this correlation are rarely reported, especially in the Chinese population. The aim of present study was to explore the relationship of the TG/HDL-C ratio with CV risks among Chinese adults during 10-year follow-up period. MATERIALS AND METHODS We carried out a prospective study using data obtained from 96,542 individuals in Kailuan, who were grouped through the median value (0.8533) of the TG/HDL-C ratio. Adverse outcomes mainly referred to major CV events. We used the person-years incidence and cumulative incidence to predict the morbidity. The risk of CV events was estimated through Cox proportional hazard models. RESULTS The mean age of the cohort was 51.5 ± 12.6 years, and 79.6% of participants were men. During a median follow-up period of 9.75 years, 5,422 major CV events occurred, including 1,312 myocardial infarction cases and 4,228 stroke cases. The cumulative incidence of myocardial infarction, stroke and total CV events was 1.36% (range 1.29-1.43%), 4.38% (range 4.25-4.51%) and 5.62% (range 5.47-5.76%), respectively. Compared with low the TG/HDL-C ratio (≤0.8533) group, the high TG/HDL-C ratio (>0.8533) group had higher morbidity of CV events. The hazard ratio of total CV events, stroke and myocardial infarction was 1.19 (95% CI 1.12-1.26), 1.11 (95% CI 1.03-1.18) and 1.50 (95% CI 1.33-1.70), respectively. Furthermore, the TG/HDL-C ratio and major CV events had a line-shaped relationship with each other. CONCLUSIONS Among the Chinese population, a higher TG/HDL-C ratio is correlated with an increased risk of major CV events.
Collapse
Affiliation(s)
- Zekai Chen
- Shantou University Medical CollegeShantouChina
- Department of CardiologySecond Affiliated Hospital of Shantou University Medical CollegeShantouChina
| | | | - Hailun Qin
- Shantou University Medical CollegeShantouChina
- Department of CardiologySecond Affiliated Hospital of Shantou University Medical CollegeShantouChina
| | - Zefeng Cai
- Shantou University Medical CollegeShantouChina
- Department of CardiologySecond Affiliated Hospital of Shantou University Medical CollegeShantouChina
| | - Jianhuan Huang
- Shantou University Medical CollegeShantouChina
- Department of CardiologySecond Affiliated Hospital of Shantou University Medical CollegeShantouChina
| | - Haojia Chen
- Shantou University Medical CollegeShantouChina
- Department of CardiologySecond Affiliated Hospital of Shantou University Medical CollegeShantouChina
| | - Weiqiang Wu
- Department of CardiologySecond Affiliated Hospital of Shantou University Medical CollegeShantouChina
| | - Zhichao Chen
- Department of CardiologySecond Affiliated Hospital of Shantou University Medical CollegeShantouChina
| | - Shouling Wu
- Department of CardiologyKailuan HospitalNorth China University of Science and TechnologyTangshanChina
| | - Youren Chen
- Department of CardiologySecond Affiliated Hospital of Shantou University Medical CollegeShantouChina
| |
Collapse
|
33
|
Qin H, Chen Z, Zhang Y, Wang L, Ouyang P, Cheng L, Zhang Y. Triglyceride to high-density lipoprotein cholesterol ratio is associated with incident diabetes in men: A retrospective study of Chinese individuals. J Diabetes Investig 2020; 11:192-198. [PMID: 31145539 PMCID: PMC6944823 DOI: 10.1111/jdi.13087] [Citation(s) in RCA: 21] [Impact Index Per Article: 5.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 03/25/2019] [Revised: 05/04/2019] [Accepted: 05/25/2019] [Indexed: 02/05/2023] Open
Abstract
AIMS/INTRODUCTION Dyslipidemia is commonly present in type 2 diabetes mellitus patients. Recently, the triglyceride : high-density lipoprotein cholesterol (TG/HDL-C) ratio, a novel parameter of lipid abnormality, has been seen as an independent predictor for incident diabetes. However, the correlation of the TG/HDL-C ratio with incident diabetes in the Chinese population and how this relationship is impacted by sex have been rarely studied. In the present study, the correlation of the TG/HDL-C ratio with incident diabetes is investigated between different sexes of the Chinese population. MATERIALS AND METHODS A total of 116,855 participants who were free of diabetes at baseline were enrolled in the study. The participants were grouped by the median value (0.82) of the TG/HDL-C ratio. Then, participants were further analyzed according to their sex. Cumulative incidence and person-years incidence were used to express the incidence rate. The predictive value of the TG/HDL-C ratio for incident diabetes was probed by the Cox regression proportional hazards model. RESULTS The mean age of the participants was 44.1 ± 12.9 years, and 53% of participants (n = 62,868) were the men. A total of 2,685 incident diabetes cases occurred during the 3.1 years of the median follow-up period. The cumulative incidence in total incident diabetes patients, men and women was 2.30% (2.21-2.38%), 3.01% (2.87-3.14%) and 1.47% (1.37-1.57%), respectively. After the adjustment of multivariate factors, the multivariate Cox regression analysis results showed that a higher TG/HDL-C ratio was the independent predictive factor of incident diabetes in men (hazard ratio 1.30, 95% confidence interval 1.03-1.64), compared with women (hazard ratio 0.85, 95% confidence interval 0.53-1.38). CONCLUSIONS Among the Chinese population, the TG/HDL-C ratio is an independent predictor for incident diabetes in male patients.
Collapse
Affiliation(s)
- Hailun Qin
- Department of CardiologyThe Second Affiliated Hospital of Shantou University Medical CollegeShantouGuangdongChina
- Cardiovascular LaboratoryCentre for Translational MedicineThe Second Affiliated Hospital of Shantou University Medical CollegeShantouGuangdongChina
| | - Zekai Chen
- Department of CardiologyThe Second Affiliated Hospital of Shantou University Medical CollegeShantouGuangdongChina
- Cardiovascular LaboratoryCentre for Translational MedicineThe Second Affiliated Hospital of Shantou University Medical CollegeShantouGuangdongChina
| | - Yunzhang Zhang
- Department of CardiologyThe Second Affiliated Hospital of Shantou University Medical CollegeShantouGuangdongChina
- Cardiovascular LaboratoryCentre for Translational MedicineThe Second Affiliated Hospital of Shantou University Medical CollegeShantouGuangdongChina
| | - Lingyu Wang
- Department of CardiologyThe Second Affiliated Hospital of Shantou University Medical CollegeShantouGuangdongChina
- Cardiovascular LaboratoryCentre for Translational MedicineThe Second Affiliated Hospital of Shantou University Medical CollegeShantouGuangdongChina
| | - Piao Ouyang
- Department of CardiologyThe Second Affiliated Hospital of Shantou University Medical CollegeShantouGuangdongChina
- Cardiovascular LaboratoryCentre for Translational MedicineThe Second Affiliated Hospital of Shantou University Medical CollegeShantouGuangdongChina
| | - Lan Cheng
- Department of CardiologyThe Second Affiliated Hospital of Shantou University Medical CollegeShantouGuangdongChina
- Cardiovascular LaboratoryCentre for Translational MedicineThe Second Affiliated Hospital of Shantou University Medical CollegeShantouGuangdongChina
| | - Yonggang Zhang
- Department of CardiologyThe Second Affiliated Hospital of Shantou University Medical CollegeShantouGuangdongChina
- Cardiovascular LaboratoryCentre for Translational MedicineThe Second Affiliated Hospital of Shantou University Medical CollegeShantouGuangdongChina
| |
Collapse
|
34
|
Cheng Y, Wang Q, Li K, Shi J, Liu Y, Wu L, Han B, Chen G, He J, Wang J, Lou D, Yu H, Qin H, Li XL. Overall survival (OS) update in ALTER 1202: Anlotinib as third-line or further-line treatment in relapsed small-cell lung cancer (SCLC). Ann Oncol 2019. [DOI: 10.1093/annonc/mdz264.002] [Citation(s) in RCA: 20] [Impact Index Per Article: 4.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/12/2022] Open
|
35
|
Li K, Cheng Y, Wang Q, Shi J, Han B, Wu L, Chen G, He J, Wang J, Qin H, Li X. P2.12-11 Quality of Life in ALTER1202 Trial of Anlotinib as Third-or Further Line Therapy for Advanced Small Cell Lung Cancer (SCLC): A Post-Hoc Analysis. J Thorac Oncol 2019. [DOI: 10.1016/j.jtho.2019.08.1756] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/25/2022]
|
36
|
Wang Q, Cheng Y, Li K, Shi J, Han B, Wu L, Chen G, He J, Wang J, Qin H, Li X. OA03.02 Effect of Anlotinib in Advanced Small Cell Lung Cancer Patients Previously Received Chemoradiotherapy: A Subgroup Analysis in ALTER 1202 Trial. J Thorac Oncol 2019. [DOI: 10.1016/j.jtho.2019.08.418] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/27/2022]
|
37
|
Cheng Y, Wang Q, Li K, Shi J, Han B, Wu L, Chen G, He J, Wang J, Qin H, Li X. P2.12-26 The Impact of Anlotinib for Relapsed SCLC Patients with Brain Metastases: A Subgroup Analysis of ALTER 1202. J Thorac Oncol 2019. [DOI: 10.1016/j.jtho.2019.08.1771] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/17/2022]
|
38
|
Huang L, Qin H. SUN-PO068: The Function of Arachidonic Acid (AA) in Chronic Constipation During Synbiotics Treatment. Clin Nutr 2019. [DOI: 10.1016/s0261-5614(19)32702-5] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/15/2022]
|
39
|
Chen Z, Qin H, Qiu S, Chen G, Chen Y. Correlation of triglyceride to high-density lipoprotein cholesterol ratio with nonalcoholic fatty liver disease among the non-obese Chinese population with normal blood lipid levels: a retrospective cohort research. Lipids Health Dis 2019; 18:162. [PMID: 31399032 PMCID: PMC6689160 DOI: 10.1186/s12944-019-1104-6] [Citation(s) in RCA: 39] [Impact Index Per Article: 7.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/09/2019] [Accepted: 08/01/2019] [Indexed: 02/05/2023] Open
Abstract
BACKGROUND Although nonalcoholic fatty liver disease (NAFLD) is commonly seen in metabolic abnormalities patients, NAFLD is also occurred in the non-obese individuals. The ratio of triglyceride to high-density lipoprotein cholesterol (TG/HDL-C) is considered as a predictive factor of NAFLD. However, it is still difficult to confirm the correlation of TG/HDL-C ratio with NAFLD among non-obese Chinese people with normal blood lipid levels. In our study, it is aimed to analyze the correlation of TG/HDL-C ratio with NAFLD among non-obese Chinese population without dyslipidemia. METHODS In the retrospective cohort study, 9838 non-obese subjects who were free of NAFLD were enrolled. NAFLD was diagnosed by ultrasonography. RESULTS During the median follow-up period of 2.9 years, cumulative incidence of NAFLD in non-obesity individuals was 8.69% among the overall population; meanwhile, its incidence was gradually enhanced across the quartiles of TG/HDL-C ratio (0.61, 1.28, 2.55 and 4.25% respectively). Then the multivariate factors were adjusted. The multivariate cox regression analysis results showed that the hazard ratio of NAFLD in higher quartiles (Q2-Q4) was 2.10 (1.33-3.32), 3.11 (2.03-4.75) and 3.40 (2.24-5.17), respectively. Besides, the area under receiver operator characteristic curve (AUC) of TG/HDL-C ratio in the male was 0.70 (0.68-0.72) and 0.72 (0.70-0.75) in the female. The final values were dramatically larger than the other lipid index. CONCLUSION There is an independent relationship between TG/HDL-C and NAFLD among non-obese Chinese population without dyslipidemia, and TG/HDL-C may be used as a better predictor for NAFLD.
Collapse
Affiliation(s)
- Zekai Chen
- Shantou University Medical College, Shantou, Guangdong, China
- Department of Cardiology, Second Affiliated Hospital of Shantou University Medical College, Shantou, Guangdong, China
| | - Hailun Qin
- Shantou University Medical College, Shantou, Guangdong, China
- Department of Cardiology, Second Affiliated Hospital of Shantou University Medical College, Shantou, Guangdong, China
| | - Shaobin Qiu
- Shantou University Medical College, Shantou, Guangdong, China
- Department of Rehabilitation Medicine, Institute of Geriatric Medicine, Guangdong Academy of Medical Sciences, Guangdong Provincial People's Hospital, Guangzhou, China
| | - Guanzhi Chen
- China Medical University, Shenyang, Liaoning, China
| | - Youren Chen
- Department of Cardiology, Second Affiliated Hospital of Shantou University Medical College, Shantou, Guangdong, China.
| |
Collapse
|
40
|
Kwak L, Qin H, Dong Z, Wang X, Cheng W, Smith D, Song J, Aldoss I, Muschen M, Forman S. Novel BAFF-R CAR T-cell Therapy for CD19 Antigen-loss Relapsed B Cell Tumors. Hematol Oncol 2019. [DOI: 10.1002/hon.123_2629] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/08/2022]
Affiliation(s)
- L.W. Kwak
- Toni Stephenson Lymphoma Center; City of Hope; Duarte United States
| | - H. Qin
- Toni Stephenson Lymphoma Center; City of Hope; Duarte United States
| | - Z. Dong
- Toni Stephenson Lymphoma Center; City of Hope; Duarte United States
| | - X. Wang
- Center for CAR T Cell Therapy; City of Hope; Duarte United States
| | - W.A. Cheng
- Toni Stephenson Lymphoma Center; City of Hope; Duarte United States
| | - D. Smith
- Toni Stephenson Lymphoma Center; City of Hope; Duarte United States
| | - J.Y. Song
- Department of Pathology; City of Hope; Duarte United States
| | - I. Aldoss
- Gehr Family Center for Leukemia Research; City of Hope; Duarte United States
| | - M. Muschen
- Department of Systems Biology; City of Hope; Duarte United States
| | - S.J. Forman
- Center for CAR T Cell Therapy; City of Hope; Duarte United States
| |
Collapse
|
41
|
Zhao LJ, Xu ZN, Li YQ, Chen YH, Qin H. A fast key parameter extraction algorithm for long fiber distributed sensing based on Brillouin scattering. Rev Sci Instrum 2019; 90:066101. [PMID: 31255036 DOI: 10.1063/1.5049738] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 07/25/2018] [Accepted: 04/15/2019] [Indexed: 06/09/2023]
Abstract
A fast key parameter extraction algorithm is proposed to improve the real-time performance of temperature and strain measurements when performing Brillouin scattering-based fiber-distributed sensing. The algorithm uses a new initial value method that takes the extracted key parameters of the current point in the fiber as the initial guesses for the next point. Based on the old and new initial value method, the existing objective method, optimization algorithm, and convergence criterion, the key parameter extraction algorithms developed are implemented in Matlab using the typical Lorentzian, Gaussian, and pseudo-Voigt profiles. These algorithms are used to extract the parameters over a large range of measured Brillouin spectra for the entire fiber with different averaging times. The results reveal that apart from the case when the frequency sweep spans is less than the linewidth and the pseudo-Voigt profile is used (in this case, the mean computation time of the proposed algorithm is 1.1% larger than that of the referenced algorithm), the proposed algorithm not only ensures high accuracy in extracting the key parameters, but also improves the arithmetic efficiency by 16.3%-49.1%.
Collapse
Affiliation(s)
- L J Zhao
- School of Electrical and Electronic Engineering, North China Electric Power University, Baoding 071003, China
| | - Z N Xu
- School of Electrical and Electronic Engineering, North China Electric Power University, Baoding 071003, China
| | - Y Q Li
- School of Electrical and Electronic Engineering, North China Electric Power University, Baoding 071003, China
| | - Y H Chen
- Science and Technology College, North China Electric Power University, Baoding 071003, China
| | - H Qin
- Grid Planning & Research Center, Guangxi Power Grid Corporation, Nanning 530000, China
| |
Collapse
|
42
|
Qin H, Xu X, Zou J, Zhao X, Wu H, Zha Q, Chen S, Kang Y, Jiang H. Krebs von den Lungen-6 associated with chest high-resolution CT score in evaluation severity of patients with interstitial lung disease. Pulmonology 2019; 25:143-148. [DOI: 10.1016/j.pulmoe.2018.05.008] [Citation(s) in RCA: 15] [Impact Index Per Article: 3.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/23/2018] [Revised: 04/28/2018] [Accepted: 05/23/2018] [Indexed: 12/18/2022] Open
|
43
|
Gui QL, Wang YS, Huang S, Wan Y, Wang HP, Zhu ZG, Li MM, Zhu HY, Tao QS, Shen YY, Zhang Q, Qin H. [Infiltration of tumor associated macrophages in multiple myeloma and its clinical significance]. Zhonghua Xue Ye Xue Za Zhi 2019; 39:122-127. [PMID: 29562446 PMCID: PMC7342570 DOI: 10.3760/cma.j.issn.0253-2727.2018.02.009] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Indexed: 12/15/2022]
Abstract
目的 探讨肿瘤相关性巨噬细胞(TAM)在多发性骨髓瘤(MM)中的临床意义及其与肿瘤血管生成、免疫抑制的关系。 方法 以2015年8月至2017年6月就诊的70例MM患者为观察对象,以20例良性血液病(缺铁性贫血13例,巨幼细胞性贫血7例)患者为对照,采用免疫组化法检测骨髓标本中CD163、CD34、VEGF的表达,采用流式细胞术检测Treg细胞比例,采用ELISA法检测IL-10水平,结合临床特征进行分析。 结果 ①70例患者中,男31例,女39例,中位年龄65(50~78)岁。MM患者组的TAM浸润密度、微血管密度(MVD)、VEGF表达水平、Treg细胞比例及IL-10水平均较对照组升高(P值均<0.05)。②在MM患者组中,疾病稳定组(15例)患者的上述指标均较初诊组(35例)和复发难治组(20例)低(P值均<0.05);后两组差异无统计学意义(P值均>0.05)。③35例初诊MM患者中27例完成4个疗程治疗,有效组(15例)治疗后TAM浸润密度较治疗前明显下降,差异有统计学意义[(20.20±7.66)对(28.87±11.97)个/高倍,t=2.362,P=0.025];无效组(12例)治疗前后差异无统计学意义[(42.00±13.76)对(48.25±13.59)个/高倍,t=1.119,P=0.275]。④硼替佐米方案治疗有效组患者(21例次)的TAM浸润密度较非硼替佐米方案治疗有效组(18例次)减低[(16.52±4.26)对(19.27±5.82)个/高倍,t=1.662,P=0.170]。⑤MM患者的TAM浸润密度与MVD、VEGF表达水平、Treg细胞比例及IL-10水平呈正相关(P值均<0.001)。 结论 骨髓微环境中浸润的TAM与MM发生、发展、疗效及治疗耐药有关,其作用机制可能与TAM促进肿瘤血管形成及抑制免疫反应有关。
Collapse
Affiliation(s)
- Q L Gui
- Department of Hematology the Second Affiliated Hospital of Medical University Of Anhui, Hefei 230601, China
| | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
44
|
Chen S, Wang Y, Qin H, Lin J, Xie L, Chen S, Liang J, Xu J. Downregulation of miR-633 activated AKT/mTOR pathway by targeting AKT1 in lupus CD4+ T cells. Lupus 2019; 28:510-519. [PMID: 30760089 DOI: 10.1177/0961203319829853] [Citation(s) in RCA: 14] [Impact Index Per Article: 2.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/14/2023]
Abstract
Background Accumulating evidence suggests that the AKT/mTOR pathway plays an important role in the pathogenesis of systemic lupus erythematosus (SLE) through activating T cells, and there are few studies looking into the role of microRNA (miRNAs) in the mechanism. We first found that miR-633 expression in CD4+T cells of SLE patients was significantly reduced. Objective To investigate the role of miR-633 in the AKT/mTOR pathway in lupus CD4+T cells. Methods Samples of 17 SLE cases and 16 healthy controls were collected to detect the expression of miR-633, AKT1, mTOR mRNA and proteins by quantitative polymerase chain reaction (qPCR) and Western-blot, respectively. To determine whether AKT1 is a direct target of miR-633, a luciferase assay was performed. In vitro, AKT1 siRNA, miR-633 mimics/inhibitors or negative controls were transfected to Jurkat cells, human primary CD4+T cells and lupus CD4+T cells. RNA and proteins were extracted after 48 h, and levels of AKT/mTOR pathway markers and downstream multiple cytokines were detected by qPCR or Western-blot. Results In SLE patients, the miR-633 levels in CD4+T cells were significantly decreased and negatively correlated with SLEDAI. AKT1, mTOR mRNA and proteins were all up-regulated. The degree of downregulation of miR-633 was correlated negatively with AKT1 mRNA. The luciferase assay proved that AKT1 is a direct target of miR-633. In Jurkat and lupus CD4+T cells, overexpression of miR-633 could result in lower levels of AKT1 and mTOR. Inhibition of miR-633 expression in primary CD4+T cells caused reverse effects, and protein levels of p-AKT, p-mTOR, and p-S6RP increased. Moreover, among various cytokines, the expression of IL-4, IL-17, and IFN-γ mRNA was raised. Conclusion Our study suggests that miR-633 deletion can activate the AKT/mTOR pathway by targeting AKT1 to participate in the pathogenesis of SLE.
Collapse
Affiliation(s)
- S Chen
- Department of Dermatology, Huashan Hospital, Fudan University, Shanghai, China
| | - Y Wang
- Department of Dermatology, Huashan Hospital, Fudan University, Shanghai, China
| | - H Qin
- Department of Dermatology, Huashan Hospital, Fudan University, Shanghai, China
| | - J Lin
- Department of Dermatology, Huashan Hospital, Fudan University, Shanghai, China
| | - L Xie
- Department of Dermatology, Huashan Hospital, Fudan University, Shanghai, China
| | - S Chen
- Department of Dermatology, Huashan Hospital, Fudan University, Shanghai, China
| | - J Liang
- Department of Dermatology, Huashan Hospital, Fudan University, Shanghai, China
| | - J Xu
- Department of Dermatology, Huashan Hospital, Fudan University, Shanghai, China
- Shanghai Institute of Dermatology, Shanghai, China
| |
Collapse
|
45
|
Yang F, Wang S, Qin H, Tan K, Sun QQ, Wang LX, Nie SS, Liu JN, Chen Y, Zhang M, Chen YY. [Frailty progress and related factors in the elderly living in community: a prospective study]. Zhonghua Liu Xing Bing Xue Za Zhi 2019; 40:186-190. [PMID: 30744270 DOI: 10.3760/cma.j.issn.0254-6450.2019.02.012] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Subscribe] [Scholar Register] [Indexed: 02/05/2023]
Abstract
Objective: To investigate frailty progress status and related factors in the elderly living in communities. Methods: A cohort of elderly people aged 65 and over in Pingyi community of Dujiangyan, Sichuan province, was established. Face-to-face questionnaire survey was conducted by trained interviewers. The frailty status, cognitive function, nutrition status and other functions of the subjects surveyed were evaluated at baseline survey and during follow-up. The socio-demographic and clinical characteristics of the subjects surveyed were assessed at baseline survey. Binary logistic regressions were used to identify factors associated with frailty progress. Results: A total of 653 elderly people were surveyed in January 2014, and 507 elderly people were followed up while 146 elderly people terminated further follow-up in January 2017. The prevalence rates of frailty and pre-frailty at baseline survey were 11.2% (n=57) and 26.2% (n=133), respectively. After 3 years, 205 subjects (40.4%) surveyed experienced frailty progress, 276 (54.5%) remained to be in frailty state at baseline survey, and 26 (5.1%) had improvement. Disability (OR=8.27, 95%CI: 1.62-42.26), visual problem (OR=2.02, 95%CI: 1.27-3.22), cognitive impairment (OR=1.94, 95%CI: 1.08-3.48), poor self-rated health (OR=1.89, 95%CI: 1.07-3.31), chronic pain (OR=1.57, 95%CI: 1.03-2.40) and older age (OR=1.12, 95%CI: 1.08-1.17) were independently associated with the progress of frailty. In contract, overweight was a protective factor (OR=0.54, 95%CI: 0.34-0.85). Conclusions: Frailty is a dynamic syndrome affected by several socio-demographic factors and geriatric factors. The results of the study can be used in the prevention of frailty progress in the elderly in communities.
Collapse
Affiliation(s)
- F Yang
- Center of Gerontology and Geriatrics, West China Hospital, Sichuan University, Chengdu 610041, China
| | - S Wang
- Center of Gerontology and Geriatrics, West China Hospital, Sichuan University, Chengdu 610041, China
| | - H Qin
- Internal Medicine Department, Pingyi Community Health Service Center in Dujiangyan, Dujiangyan 610000, China
| | - K Tan
- Center of Gerontology and Geriatrics, West China Hospital, Sichuan University, Chengdu 610041, China
| | - Q Q Sun
- Center of Gerontology and Geriatrics, West China Hospital, Sichuan University, Chengdu 610041, China
| | - L X Wang
- Geriatric Department, the Fifth People's Hospital of Chengdu, Chengdu 611130, China
| | - S S Nie
- General Medicine Department, the Affiliated Central Hospital of Qingdao University, Qingdao 266071, China
| | - J N Liu
- Center of Gerontology and Geriatrics, West China Hospital, Sichuan University, Chengdu 610041, China
| | - Y Chen
- Department of Palliative Medicine, the Fourth West China Teaching Hospital, Sichuan University, Chengdu 610041, China
| | - M Zhang
- Department of Elderly Endocrinology, Sichuan Provincial People's Hospital, Chengdu 610072, China
| | - Y Y Chen
- Center of Gerontology and Geriatrics, West China Hospital, Sichuan University, Chengdu 610041, China
| |
Collapse
|
46
|
Cheng Y, Wang Q, Li K, Shi J, Wu L, Han B, Chen G, He J, Wang J, Qin H, Li X. OA13.03 Anlotinib as Third-Line or Further-Line Treatment in Relapsed SCLC: A Multicentre, Randomized, Double-Blind Phase 2 Trial. J Thorac Oncol 2018. [DOI: 10.1016/j.jtho.2018.08.308] [Citation(s) in RCA: 11] [Impact Index Per Article: 1.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/13/2022]
|
47
|
Feng F, Cheng Q, Zhang D, Li B, Qin H, Xu C, Han M, Yu Y, Li Z, Li JY, Qiu Z, Xiong L, Liu C, Li F, Yi B, Jiang X. Targeted therapy based on the genetic alterations prolongs the progression-free survival of patients with advanced biliary tract cancer. Ann Oncol 2018. [DOI: 10.1093/annonc/mdy282.137] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
|
48
|
|
49
|
Song W, Zhao L, Tao Y, Guo X, Jia J, He L, Huang Y, Zhu Y, Chen P, Qin H. The interruptive effect of electric shock on odor response requires mushroom bodies in Drosophila melanogaster. Genes Brain Behav 2018; 18:e12488. [PMID: 29808570 DOI: 10.1111/gbb.12488] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Subscribe] [Scholar Register] [Received: 01/24/2018] [Revised: 05/01/2018] [Accepted: 05/24/2018] [Indexed: 11/28/2022]
Abstract
Nociceptive stimulus involuntarily interrupts concurrent activities. This interruptive effect is related to the protective function of nociception that is believed to be under stringent evolutionary pressure. To determine whether such interruptive effect is conserved in invertebrate and potentially uncover underlying neural circuits, we examined Drosophila melanogaster. Electric shock (ES) is a commonly used nociceptive stimulus for nociception related research in Drosophila. Here, we showed that background noxious ES dramatically interrupted odor response behaviors in a T-maze, which is termed blocking odor response by electric shock (BOBE). The interruptive effect is not odor specific. ES could interrupt both odor avoidance and odor approach. To identify involved brain areas, we focused on the odor avoidance to 3-OCT. By spatially abolishing neurotransmission with temperature sensitive ShibireTS1 , we found that mushroom bodies (MBs) are necessary for BOBE. Among the 3 major MB Kenyon cell (KCs) subtypes, α/β neurons and γ neurons but not α'/β' neurons are required for normal BOBE. Specifically, abolishing the neurotransmission of either α/β surface (α/βs ), α/β core (α/βc ) or γ dorsal (γd ) neurons alone is sufficient to abrogate BOBE. This pattern of MB subset requirement is distinct from that of aversive olfactory learning, indicating a specialized BOBE pathway. Consistent with this idea, BOBE was not diminished in several associative memory mutants and noxious ES interrupted both innate and learned odor avoidance. Overall, our results suggest that MB α/β and γ neurons are parts of a previously unappreciated central neural circuit that processes the interruptive effect of nociception.
Collapse
Affiliation(s)
- W Song
- State Key Laboratory of Chemo/Biosensing and Chemometrics, College of Biology, Hunan University, Changsha, China
| | - L Zhao
- State Key Laboratory of Chemo/Biosensing and Chemometrics, College of Biology, Hunan University, Changsha, China
| | - Y Tao
- School of Pharmaceutical Science & Yunnan Key Laboratory of Pharmacology for Natural Products, Kunming Medical University, Kunming, China
| | - X Guo
- State Key Laboratory of Chemo/Biosensing and Chemometrics, College of Biology, Hunan University, Changsha, China
| | - J Jia
- State Key Laboratory of Chemo/Biosensing and Chemometrics, College of Biology, Hunan University, Changsha, China
| | - L He
- State Key Laboratory of Chemo/Biosensing and Chemometrics, College of Biology, Hunan University, Changsha, China
| | - Y Huang
- College of Electrical Engineering, Guangxi University, Nanning, China
| | - Y Zhu
- State Key Laboratory of Brain and Cognitive Science, Institute of Biophysics, Chinese Academy of Sciences, Beijing, China.,University of the Chinese Academy of Sciences, Beijing, China
| | - P Chen
- School of Pharmaceutical Science & Yunnan Key Laboratory of Pharmacology for Natural Products, Kunming Medical University, Kunming, China
| | - H Qin
- State Key Laboratory of Chemo/Biosensing and Chemometrics, College of Biology, Hunan University, Changsha, China
| |
Collapse
|
50
|
|